US6309669B1
(en)
*
|
1984-03-16 |
2001-10-30 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
|
US5693343A
(en)
|
1984-03-16 |
1997-12-02 |
The United States Of America As Represented By The Secretary Of The Army |
Microparticle carriers of maximal uptake capacity by both M cells and non-M cells
|
US20030161889A1
(en)
*
|
1984-03-16 |
2003-08-28 |
Reid Robert H. |
Vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
US6410056B1
(en)
|
1984-03-16 |
2002-06-25 |
The United States Of America As Represented By The Secretary Of The Army |
Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix
|
US6217911B1
(en)
|
1995-05-22 |
2001-04-17 |
The United States Of America As Represented By The Secretary Of The Army |
sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
|
USRE40786E1
(en)
|
1984-03-16 |
2009-06-23 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccines against intracellular pathogens using antigens encapsulated within biodegradable-biocompatible microspheres
|
US5904717A
(en)
*
|
1986-01-28 |
1999-05-18 |
Thm Biomedical, Inc. |
Method and device for reconstruction of articular cartilage
|
US5575815A
(en)
*
|
1988-08-24 |
1996-11-19 |
Endoluminal Therapeutics, Inc. |
Local polymeric gel therapy
|
US5749915A
(en)
*
|
1988-08-24 |
1998-05-12 |
Focal, Inc. |
Polymeric endoluminal paving process
|
JP2836878B2
(en)
|
1988-08-24 |
1998-12-14 |
スリピアン,マービン,ジェイ |
Intraluminal sealing with biodegradable polymer material
|
US4938763B1
(en)
*
|
1988-10-03 |
1995-07-04 |
Atrix Lab Inc |
Biodegradable in-situ forming implants and method of producing the same
|
US5725491A
(en)
*
|
1988-10-03 |
1998-03-10 |
Atrix Laboratories, Inc. |
Method of forming a biodegradable film dressing on tissue
|
US5632727A
(en)
*
|
1988-10-03 |
1997-05-27 |
Atrix Laboratories, Inc. |
Biodegradable film dressing and method for its formation
|
US5702716A
(en)
*
|
1988-10-03 |
1997-12-30 |
Atrix Laboratories, Inc. |
Polymeric compositions useful as controlled release implants
|
US5077049A
(en)
*
|
1989-07-24 |
1991-12-31 |
Vipont Pharmaceutical, Inc. |
Biodegradable system for regenerating the periodontium
|
US5324519A
(en)
*
|
1989-07-24 |
1994-06-28 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
US5487897A
(en)
*
|
1989-07-24 |
1996-01-30 |
Atrix Laboratories, Inc. |
Biodegradable implant precursor
|
USRE37950E1
(en)
|
1990-04-24 |
2002-12-31 |
Atrix Laboratories |
Biogradable in-situ forming implants and methods of producing the same
|
US5269785A
(en)
*
|
1990-06-28 |
1993-12-14 |
Bonutti Peter M |
Apparatus and method for tissue removal
|
US5626863A
(en)
*
|
1992-02-28 |
1997-05-06 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
US5410016A
(en)
*
|
1990-10-15 |
1995-04-25 |
Board Of Regents, The University Of Texas System |
Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
|
US5462990A
(en)
*
|
1990-10-15 |
1995-10-31 |
Board Of Regents, The University Of Texas System |
Multifunctional organic polymers
|
US5620700A
(en)
*
|
1990-10-30 |
1997-04-15 |
Alza Corporation |
Injectable drug delivery system and method
|
WO1992019263A1
(en)
|
1991-04-24 |
1992-11-12 |
The United States Of America, As Represented By The Secretary Of The Army |
Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
US6503277B2
(en)
*
|
1991-08-12 |
2003-01-07 |
Peter M. Bonutti |
Method of transplanting human body tissue
|
AU2605592A
(en)
*
|
1991-10-15 |
1993-04-22 |
Atrix Laboratories, Inc. |
Polymeric compositions useful as controlled release implants
|
WO1993015787A1
(en)
*
|
1992-02-12 |
1993-08-19 |
Chandler Jerry W |
Biodegradable stent
|
US5573934A
(en)
|
1992-04-20 |
1996-11-12 |
Board Of Regents, The University Of Texas System |
Gels for encapsulation of biological materials
|
DK0627911T3
(en)
|
1992-02-28 |
2000-11-20 |
Univ Texas |
Photopolymerizable biodegradable hydrogels as tissue contact materials and controlled release carriers
|
EP0560014A1
(en)
*
|
1992-03-12 |
1993-09-15 |
Atrix Laboratories, Inc. |
Biodegradable film dressing and method for its formation
|
US5384333A
(en)
*
|
1992-03-17 |
1995-01-24 |
University Of Miami |
Biodegradable injectable drug delivery polymer
|
US5540240A
(en)
*
|
1992-03-26 |
1996-07-30 |
Bauer; William |
Intranasal septal fastener driving method
|
US5370294A
(en)
*
|
1992-03-26 |
1994-12-06 |
Bauer; William |
Intranasal septal stapling device and method
|
FR2689400B1
(en)
*
|
1992-04-03 |
1995-06-23 |
Inoteb |
BONE PROSTHESIS MATERIAL CONTAINING CALCIUM CARBONATE PARTICLES DISPERSED IN A BIORESORBABLE POLYMER MATRIX.
|
GB9211268D0
(en)
*
|
1992-05-28 |
1992-07-15 |
Ici Plc |
Salts of basic peptides with carboxyterminated polyesters
|
US5242910A
(en)
†
|
1992-10-13 |
1993-09-07 |
The Procter & Gamble Company |
Sustained release compositions for treating periodontal disease
|
US5910520A
(en)
*
|
1993-01-15 |
1999-06-08 |
Mcneil-Ppc, Inc. |
Melt processable biodegradable compositions and articles made therefrom
|
US5800373A
(en)
*
|
1995-03-23 |
1998-09-01 |
Focal, Inc. |
Initiator priming for improved adherence of gels to substrates
|
US5749968A
(en)
*
|
1993-03-01 |
1998-05-12 |
Focal, Inc. |
Device for priming for improved adherence of gels to substrates
|
ES2123135T3
(en)
*
|
1993-03-23 |
1999-01-01 |
Focal Inc |
APPARATUS AND METHOD FOR LOCAL APPLICATION OF POLYMERIC MATERIAL TO FABRIC.
|
US6004547A
(en)
|
1997-09-29 |
1999-12-21 |
Focal, Inc. |
Apparatus and method for local application of polymeric material to tissue
|
US5321113A
(en)
*
|
1993-05-14 |
1994-06-14 |
Ethicon, Inc. |
Copolymers of an aromatic anhydride and aliphatic ester
|
US6939546B2
(en)
|
1993-05-21 |
2005-09-06 |
The United States Of America As Represented By The Secretary Of The Army |
Model for testing immunogenicity of peptides
|
US5425949A
(en)
*
|
1993-06-11 |
1995-06-20 |
United States Surgical Corporation |
Bioabsorbable copolymer and coating composition containing same
|
US5925065A
(en)
*
|
1993-06-11 |
1999-07-20 |
United States Surgical Corporation |
Coated gut suture
|
CA2123647C
(en)
*
|
1993-06-11 |
2007-04-17 |
Steven L. Bennett |
Bioabsorbable copolymer and coating composition containing same
|
WO1995003036A1
(en)
|
1993-07-19 |
1995-02-02 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic compositions and methods of use
|
US6908910B2
(en)
*
|
1993-08-06 |
2005-06-21 |
The Children's Medical Center Corporation |
Estrogenic compounds as anti-mitotic agents
|
CA2128912A1
(en)
*
|
1993-08-17 |
1995-02-18 |
Zygmunt Teodorczyk |
Modified phenol-aldehyde resin and binder system
|
US5468855A
(en)
*
|
1993-09-09 |
1995-11-21 |
Ciba-Geigy Corporation |
Bislactones
|
US5681873A
(en)
*
|
1993-10-14 |
1997-10-28 |
Atrix Laboratories, Inc. |
Biodegradable polymeric composition
|
US5736160A
(en)
*
|
1993-10-28 |
1998-04-07 |
Thm Biomedical, Inc. |
Process and device for treating and healing a bone void
|
FR2715309B1
(en)
*
|
1994-01-24 |
1996-08-02 |
Imedex |
Adhesive composition, for surgical use, based on collagen modified by oxidative cutting and not crosslinked.
|
CA2140053C
(en)
*
|
1994-02-09 |
2000-04-04 |
Joel S. Rosenblatt |
Collagen-based injectable drug delivery system and its use
|
US5942496A
(en)
*
|
1994-02-18 |
1999-08-24 |
The Regent Of The University Of Michigan |
Methods and compositions for multiple gene transfer into bone cells
|
US20020193338A1
(en)
*
|
1994-02-18 |
2002-12-19 |
Goldstein Steven A. |
In vivo gene transfer methods for wound healing
|
US5962427A
(en)
*
|
1994-02-18 |
1999-10-05 |
The Regent Of The University Of Michigan |
In vivo gene transfer methods for wound healing
|
US5502092A
(en)
*
|
1994-02-18 |
1996-03-26 |
Minnesota Mining And Manufacturing Company |
Biocompatible porous matrix of bioabsorbable material
|
US6074840A
(en)
*
|
1994-02-18 |
2000-06-13 |
The Regents Of The University Of Michigan |
Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)
|
US5763416A
(en)
*
|
1994-02-18 |
1998-06-09 |
The Regent Of The University Of Michigan |
Gene transfer into bone cells and tissues
|
US6551618B2
(en)
|
1994-03-15 |
2003-04-22 |
University Of Birmingham |
Compositions and methods for delivery of agents for neuronal regeneration and survival
|
PT754032E
(en)
*
|
1994-04-08 |
2002-05-31 |
Atrix Lab Inc |
LIQUID COMPOSITIONS FOR DIFFUSE
|
US5556429A
(en)
*
|
1994-05-06 |
1996-09-17 |
Advanced Bio Surfaces, Inc. |
Joint resurfacing system
|
US20050043808A1
(en)
*
|
1994-05-06 |
2005-02-24 |
Advanced Bio Surfaces, Inc. |
Knee joint prosthesis
|
US6140452A
(en)
*
|
1994-05-06 |
2000-10-31 |
Advanced Bio Surfaces, Inc. |
Biomaterial for in situ tissue repair
|
WO1998020939A2
(en)
*
|
1996-11-15 |
1998-05-22 |
Advanced Bio Surfaces, Inc. |
Biomaterial system for in situ tissue repair
|
US5981825A
(en)
|
1994-05-13 |
1999-11-09 |
Thm Biomedical, Inc. |
Device and methods for in vivo culturing of diverse tissue cells
|
US6855331B2
(en)
|
1994-05-16 |
2005-02-15 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
US6447796B1
(en)
|
1994-05-16 |
2002-09-10 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
DK63894A
(en)
*
|
1994-06-06 |
1996-01-08 |
Meadox Medicals Inc |
Stent catheter and method for making such a stent catheter
|
US5665063A
(en)
*
|
1994-06-24 |
1997-09-09 |
Focal, Inc. |
Methods for application of intraluminal photopolymerized gels
|
US5531735A
(en)
*
|
1994-09-27 |
1996-07-02 |
Hercules Incorporated |
Medical devices containing triggerable disintegration agents
|
US6335383B1
(en)
|
1994-10-18 |
2002-01-01 |
Ethicon, Inc. |
Microdispersions for coating surgical devices
|
US5900245A
(en)
|
1996-03-22 |
1999-05-04 |
Focal, Inc. |
Compliant tissue sealants
|
WO1996029370A2
(en)
*
|
1995-03-23 |
1996-09-26 |
Focal, Inc. |
Redox and photoinitiator systems for priming for improved adherence of gels to substrates
|
EP0814774B1
(en)
|
1995-03-24 |
2005-10-19 |
Genzyme Corporation |
Reduction of adhesions using controlled delivery of active oxygen inhibitors
|
US5612052A
(en)
*
|
1995-04-13 |
1997-03-18 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
US6551610B2
(en)
|
1995-04-13 |
2003-04-22 |
Poly-Med, Inc. |
Multifaceted compositions for post-surgical adhesion prevention
|
US6413539B1
(en)
|
1996-10-31 |
2002-07-02 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
AU5069796A
(en)
*
|
1995-04-28 |
1996-11-07 |
Ethicon Inc. |
Solventless tipping of braided surgical ligature
|
US7033608B1
(en)
|
1995-05-22 |
2006-04-25 |
The United States Of America As Represented By The Secretary Of The Army |
“Burst-free” sustained release poly-(lactide/glycolide) microspheres
|
US6902743B1
(en)
|
1995-05-22 |
2005-06-07 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
|
US5968542A
(en)
*
|
1995-06-07 |
1999-10-19 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system as a device
|
US5722950A
(en)
*
|
1995-06-07 |
1998-03-03 |
Atrix Laboratories, Inc. |
Method for remote delivery of an aerosolized liquid
|
US6413536B1
(en)
|
1995-06-07 |
2002-07-02 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system and medical or surgical device
|
US5747058A
(en)
*
|
1995-06-07 |
1998-05-05 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system
|
US5779673A
(en)
*
|
1995-06-26 |
1998-07-14 |
Focal, Inc. |
Devices and methods for application of intraluminal photopolymerized gels
|
US5667767A
(en)
*
|
1995-07-27 |
1997-09-16 |
Micro Therapeutics, Inc. |
Compositions for use in embolizing blood vessels
|
US5580568A
(en)
*
|
1995-07-27 |
1996-12-03 |
Micro Therapeutics, Inc. |
Cellulose diacetate compositions for use in embolizing blood vessels
|
JPH11510837A
(en)
*
|
1995-07-28 |
1999-09-21 |
フォーカル,インコーポレイテッド |
Multi-block biodegradable hydrogels for use as controlled release and tissue treatment agents for drug delivery
|
US5702717A
(en)
*
|
1995-10-25 |
1997-12-30 |
Macromed, Inc. |
Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
|
US5665428A
(en)
*
|
1995-10-25 |
1997-09-09 |
Macromed, Inc. |
Preparation of peptide containing biodegradable microspheres by melt process
|
US7888466B2
(en)
|
1996-01-11 |
2011-02-15 |
Human Genome Sciences, Inc. |
Human G-protein chemokine receptor HSATU68
|
US5980945A
(en)
*
|
1996-01-16 |
1999-11-09 |
Societe De Conseils De Recherches Et D'applications Scientifique S.A. |
Sustained release drug formulations
|
US5997568A
(en)
*
|
1996-01-19 |
1999-12-07 |
United States Surgical Corporation |
Absorbable polymer blends and surgical articles fabricated therefrom
|
US6368586B1
(en)
|
1996-01-26 |
2002-04-09 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
US5985312A
(en)
*
|
1996-01-26 |
1999-11-16 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers
|
US5702361A
(en)
|
1996-01-31 |
1997-12-30 |
Micro Therapeutics, Inc. |
Method for embolizing blood vessels
|
PT882085E
(en)
*
|
1996-02-20 |
2002-12-31 |
Massachusetts Inst Technology |
BIODEGRADABLE POLYMER NETWORKS FOR USE IN ORTHOPEDIC AND DENTAL APPLICATIONS
|
US5747060A
(en)
*
|
1996-03-26 |
1998-05-05 |
Euro-Celtique, S.A. |
Prolonged local anesthesia with colchicine
|
US5921954A
(en)
*
|
1996-07-10 |
1999-07-13 |
Mohr, Jr.; Lawrence G. |
Treating aneurysms by applying hardening/softening agents to hardenable/softenable substances
|
US7022105B1
(en)
*
|
1996-05-06 |
2006-04-04 |
Novasys Medical Inc. |
Treatment of tissue in sphincters, sinuses and orifices
|
IL118235A0
(en)
*
|
1996-05-13 |
1996-09-12 |
Univ Ben Gurion |
Composition and method for forming biodegradable implants in situ and uses of these implants
|
DK0914102T3
(en)
|
1996-05-24 |
2006-01-09 |
Angiotech Pharm Inc |
Preparations and methods for treating or preventing diseases of the body canals
|
CA2252718A1
(en)
|
1996-05-31 |
1997-12-04 |
Richard J. Greff |
Compositions for use in embolizing blood vessels
|
US6103254A
(en)
*
|
1996-05-31 |
2000-08-15 |
Micro Therapeutics, Inc. |
Methods for sterilizing male mammals
|
US5955096A
(en)
*
|
1996-06-25 |
1999-09-21 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
|
US20030077317A1
(en)
*
|
1996-06-25 |
2003-04-24 |
Brown University Research Foundation |
Methods and compositions for enhancing the bioadhesive properties of polymers using organic excipients
|
US6060534A
(en)
|
1996-07-11 |
2000-05-09 |
Scimed Life Systems, Inc. |
Medical devices comprising ionically and non-ionically crosslinked polymer hydrogels having improved mechanical properties
|
US6368356B1
(en)
|
1996-07-11 |
2002-04-09 |
Scimed Life Systems, Inc. |
Medical devices comprising hydrogel polymers having improved mechanical properties
|
US8353908B2
(en)
|
1996-09-20 |
2013-01-15 |
Novasys Medical, Inc. |
Treatment of tissue in sphincters, sinuses, and orifices
|
US8003705B2
(en)
*
|
1996-09-23 |
2011-08-23 |
Incept Llc |
Biocompatible hydrogels made with small molecule precursors
|
US20090324721A1
(en)
*
|
1996-09-23 |
2009-12-31 |
Jack Kennedy |
Hydrogels Suitable For Use In Polyp Removal
|
ZA978537B
(en)
|
1996-09-23 |
1998-05-12 |
Focal Inc |
Polymerizable biodegradable polymers including carbonate or dioxanone linkages.
|
WO1998012274A1
(en)
*
|
1996-09-23 |
1998-03-26 |
Chandrashekar Pathak |
Methods and devices for preparing protein concentrates
|
US6566406B1
(en)
|
1998-12-04 |
2003-05-20 |
Incept, Llc |
Biocompatible crosslinked polymers
|
WO1998029506A1
(en)
|
1996-12-31 |
1998-07-09 |
Kimberly-Clark Worldwide, Inc. |
Water-responsive polymer compositions and method of making the same
|
US6338726B1
(en)
|
1997-02-06 |
2002-01-15 |
Vidacare, Inc. |
Treating urinary and other body strictures
|
US6630168B1
(en)
|
1997-02-20 |
2003-10-07 |
Biomedicines, Inc. |
Gel delivery vehicles for anticellular proliferative agents
|
JP2001516261A
(en)
|
1997-03-20 |
2001-09-25 |
フォーカル・インコーポレーテッド |
Biodegradable tissue retractor
|
EP0980269A1
(en)
|
1997-04-30 |
2000-02-23 |
Guilford Pharmaceuticals Inc. |
Biodegradable compositions comprising poly(cycloaliphatic phosphoester) compounds, articles, and methods for using the same
|
US20060025328A1
(en)
*
|
1997-05-28 |
2006-02-02 |
Burns Patrick J |
Compositions suitable for controlled release of the hormone GnRH and its analogs
|
DE19724784A1
(en)
*
|
1997-06-05 |
1998-12-10 |
Roland Prof Dr Bodmeier |
Production of delayed drug release particles in the body
|
AU8530498A
(en)
|
1997-06-05 |
1998-12-21 |
Roland Bodmeier |
Multiphase system
|
CA2291622C
(en)
|
1997-06-06 |
2007-09-04 |
Anna Gutowska |
Reversible geling co-polymer and method of making
|
US5962006A
(en)
*
|
1997-06-17 |
1999-10-05 |
Atrix Laboratories, Inc. |
Polymer formulation for prevention of surgical adhesions
|
DE19726412A1
(en)
*
|
1997-06-21 |
1998-12-24 |
Merck Patent Gmbh |
Implant material with a carrier-drug combination
|
EP1007673B1
(en)
|
1997-07-30 |
2008-12-17 |
Emory University |
Novel bone mineralization proteins, dna, vectors, expression systems
|
US7923250B2
(en)
|
1997-07-30 |
2011-04-12 |
Warsaw Orthopedic, Inc. |
Methods of expressing LIM mineralization protein in non-osseous cells
|
US6075118A
(en)
*
|
1997-07-31 |
2000-06-13 |
Kimberly-Clark Worldwide, Inc. |
Water-responsive, biodegradable film compositions comprising polylactide and polyvinyl alcohol, and a method for making the films
|
US5952433A
(en)
*
|
1997-07-31 |
1999-09-14 |
Kimberly-Clark Worldwide, Inc. |
Modified polyactide compositions and a reactive-extrusion process to make the same
|
US5945480A
(en)
*
|
1997-07-31 |
1999-08-31 |
Kimberly-Clark Worldwide, Inc. |
Water-responsive, biodegradable fibers comprising polylactide modified polylactide and polyvinyl alcohol, and method for making the fibers
|
US6552162B1
(en)
|
1997-07-31 |
2003-04-22 |
Kimberly-Clark Worldwide, Inc. |
Water-responsive, biodegradable compositions and films and articles comprising a blend of polylactide and polyvinyl alcohol and methods for making the same
|
ZA987019B
(en)
*
|
1997-08-06 |
1999-06-04 |
Focal Inc |
Hemostatic tissue sealants
|
US9023031B2
(en)
*
|
1997-08-13 |
2015-05-05 |
Verathon Inc. |
Noninvasive devices, methods, and systems for modifying tissues
|
AUPO907697A0
(en)
|
1997-09-09 |
1997-10-02 |
Day, Robert Edward |
Chemical supplementation of bone
|
US5989463A
(en)
*
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
US6117949A
(en)
*
|
1998-10-01 |
2000-09-12 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly (lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6201072B1
(en)
|
1997-10-03 |
2001-03-13 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co- glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US6004573A
(en)
*
|
1997-10-03 |
1999-12-21 |
Macromed, Inc. |
Biodegradable low molecular weight triblock poly(lactide-co-glycolide) polyethylene glycol copolymers having reverse thermal gelation properties
|
US8668737B2
(en)
|
1997-10-10 |
2014-03-11 |
Senorx, Inc. |
Tissue marking implant
|
US6569417B2
(en)
|
1997-10-10 |
2003-05-27 |
Micro Therapeutics, Inc. |
Methods for treating urinary incontinence in mammals
|
US7637948B2
(en)
*
|
1997-10-10 |
2009-12-29 |
Senorx, Inc. |
Tissue marking implant
|
US6417247B1
(en)
*
|
1997-10-14 |
2002-07-09 |
Beth L. Armstrong |
Polymer/ceramic composites
|
CA2305349A1
(en)
*
|
1997-10-27 |
1999-05-06 |
Alexander R. Irvine |
Methods and pharmaceutical compositions for the closure of retinal breaks
|
US6193991B1
(en)
|
1997-10-29 |
2001-02-27 |
Atul J. Shukla |
Biodegradable delivery systems of biologically active substances
|
US6015541A
(en)
|
1997-11-03 |
2000-01-18 |
Micro Therapeutics, Inc. |
Radioactive embolizing compositions
|
AU758858B2
(en)
*
|
1997-11-21 |
2003-04-03 |
Interag |
Biodegradable intra vaginal devices
|
HUP0101250A3
(en)
*
|
1998-01-29 |
2006-06-28 |
Poly Med Inc Anderson |
Absorbable microparticles
|
JP2002501907A
(en)
|
1998-01-29 |
2002-01-22 |
キナートン・リミテッド |
Method for producing absorbable microparticles
|
US20100114087A1
(en)
*
|
1998-02-19 |
2010-05-06 |
Edwards Stuart D |
Methods and devices for treating urinary incontinence
|
ES2359973T3
(en)
|
1998-03-19 |
2011-05-30 |
MERCK SHARP & DOHME CORP. |
LIQUID POLYMER COMPOSITIONS FOR THE CONTROLLED RELEASE OF BIOACTIVE SUBSTANCES.
|
US6161034A
(en)
*
|
1999-02-02 |
2000-12-12 |
Senorx, Inc. |
Methods and chemical preparations for time-limited marking of biopsy sites
|
US20040228794A1
(en)
*
|
1998-04-10 |
2004-11-18 |
Battelle Memorial Institute |
Therapeutic agent carrier compositions
|
US6841617B2
(en)
*
|
2000-09-28 |
2005-01-11 |
Battelle Memorial Institute |
Thermogelling biodegradable aqueous polymer solution
|
US7087244B2
(en)
*
|
2000-09-28 |
2006-08-08 |
Battelle Memorial Institute |
Thermogelling oligopeptide polymers
|
US7128927B1
(en)
|
1998-04-14 |
2006-10-31 |
Qlt Usa, Inc. |
Emulsions for in-situ delivery systems
|
JP2002512182A
(en)
*
|
1998-04-20 |
2002-04-23 |
ジェンザイム・コーポレーション |
Drug delivery of proteins from polymer blends
|
US6177094B1
(en)
|
1998-04-30 |
2001-01-23 |
United States Surgical Corporation |
Bioabsorbable blends and coating composition containing same
|
US6350518B1
(en)
|
1998-06-01 |
2002-02-26 |
Kimberly-Clark Worldwide, Inc. |
Methods of making blend compositions of an unmodified poly vinyl alcohol and a thermoplastic elastomer
|
US6933326B1
(en)
|
1998-06-19 |
2005-08-23 |
Lifecell Coporation |
Particulate acellular tissue matrix
|
WO1999066797A1
(en)
|
1998-06-22 |
1999-12-29 |
Worden Charles E |
Enriched platelet wound healant
|
US6245345B1
(en)
|
1998-07-07 |
2001-06-12 |
Atrix Laboratories, Inc. |
Filamentous porous films and methods for producing the same
|
US6261583B1
(en)
|
1998-07-28 |
2001-07-17 |
Atrix Laboratories, Inc. |
Moldable solid delivery system
|
US6703047B2
(en)
|
2001-02-02 |
2004-03-09 |
Incept Llc |
Dehydrated hydrogel precursor-based, tissue adherent compositions and methods of use
|
US6818018B1
(en)
*
|
1998-08-14 |
2004-11-16 |
Incept Llc |
In situ polymerizable hydrogels
|
US6152943A
(en)
*
|
1998-08-14 |
2000-11-28 |
Incept Llc |
Methods and apparatus for intraluminal deposition of hydrogels
|
US6605294B2
(en)
*
|
1998-08-14 |
2003-08-12 |
Incept Llc |
Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
|
JP4159254B2
(en)
*
|
1998-08-14 |
2008-10-01 |
インセプト エルエルシー |
Method and apparatus for in situ formation of hydrogels
|
US6179862B1
(en)
|
1998-08-14 |
2001-01-30 |
Incept Llc |
Methods and apparatus for in situ formation of hydrogels
|
US6632457B1
(en)
*
|
1998-08-14 |
2003-10-14 |
Incept Llc |
Composite hydrogel drug delivery systems
|
WO2000010568A1
(en)
*
|
1998-08-24 |
2000-03-02 |
Draheim Susan E |
Methods and compositions for treating periodontal disease with an inhibitor of secretory phospholipase a¿2?
|
US6419709B1
(en)
*
|
1998-10-02 |
2002-07-16 |
Guilford Pharmaceuticals, Inc. |
Biodegradable terephthalate polyester-poly(Phosphite) compositions, articles, and methods of using the same
|
US6153212A
(en)
|
1998-10-02 |
2000-11-28 |
Guilford Pharmaceuticals Inc. |
Biodegradable terephthalate polyester-poly (phosphonate) compositions, articles, and methods of using the same
|
US7767708B2
(en)
*
|
1998-11-04 |
2010-08-03 |
Schering-Plough Animal Health Corp. |
Growth stimulant compositions
|
US20080114092A1
(en)
*
|
1998-12-04 |
2008-05-15 |
Incept Llc |
Adhesion barriers applicable by minimally invasive surgery and methods of use thereof
|
US6200550B1
(en)
|
1998-12-11 |
2001-03-13 |
Q-Pharma, Inc. |
Oral care compositions comprising coenzyme Q10
|
US6231613B1
(en)
|
1998-12-15 |
2001-05-15 |
Enteric Medical Technologies, Inc. |
Methods for soft tissue augmentation in mammals
|
US7983734B2
(en)
|
2003-05-23 |
2011-07-19 |
Senorx, Inc. |
Fibrous marker and intracorporeal delivery thereof
|
US6862470B2
(en)
|
1999-02-02 |
2005-03-01 |
Senorx, Inc. |
Cavity-filling biopsy site markers
|
US7651505B2
(en)
|
2002-06-17 |
2010-01-26 |
Senorx, Inc. |
Plugged tip delivery for marker placement
|
US6725083B1
(en)
|
1999-02-02 |
2004-04-20 |
Senorx, Inc. |
Tissue site markers for in VIVO imaging
|
US20090216118A1
(en)
*
|
2007-07-26 |
2009-08-27 |
Senorx, Inc. |
Polysaccharide markers
|
US8361082B2
(en)
|
1999-02-02 |
2013-01-29 |
Senorx, Inc. |
Marker delivery device with releasable plug
|
US9820824B2
(en)
|
1999-02-02 |
2017-11-21 |
Senorx, Inc. |
Deployment of polysaccharide markers for treating a site within a patent
|
US8498693B2
(en)
*
|
1999-02-02 |
2013-07-30 |
Senorx, Inc. |
Intracorporeal marker and marker delivery device
|
DE19908753C2
(en)
*
|
1999-02-20 |
2003-10-02 |
Jenapharm Gmbh |
Biodegradable, injectable oligomer-polymer composition
|
US6303100B1
(en)
|
1999-03-19 |
2001-10-16 |
Micro Therapeutics, Inc. |
Methods for inhibiting the formation of potential endoleaks associated with endovascular repair of abdominal aortic aneurysms
|
US6203779B1
(en)
|
1999-03-19 |
2001-03-20 |
Charlie Ricci |
Methods for treating endoleaks during endovascular repair of abdominal aortic aneurysms
|
EP2305324B1
(en)
*
|
1999-03-25 |
2014-09-17 |
Metabolix, Inc. |
Medical devices and applications of polyhydroxyalkanoate polymers
|
US6206927B1
(en)
|
1999-04-02 |
2001-03-27 |
Barry M. Fell |
Surgically implantable knee prothesis
|
US7341602B2
(en)
*
|
1999-05-10 |
2008-03-11 |
Fell Barry M |
Proportioned surgically implantable knee prosthesis
|
DE19916131A1
(en)
*
|
1999-04-09 |
2000-10-26 |
S & C Polymer Silicon & Compos |
Adhesive system for silicones
|
US6716445B2
(en)
*
|
1999-04-12 |
2004-04-06 |
Cornell Research Foundation, Inc. |
Hydrogel entrapping therapeutic agent and stent with coating comprising this
|
WO2000060956A1
(en)
|
1999-04-12 |
2000-10-19 |
Cornell Research Foundation, Inc. |
Hydrogel-forming system with hydrophobic and hydrophilic components
|
US6858229B1
(en)
|
1999-04-26 |
2005-02-22 |
California Institute Of Technology |
In situ forming hydrogels
|
AU4977800A
(en)
*
|
1999-04-26 |
2000-11-10 |
California Institute Of Technology |
(in situ) forming hydrogels
|
US6554851B1
(en)
|
1999-05-07 |
2003-04-29 |
Scimed Life Systems, Inc. |
Methods of sealing an injection site
|
US6866684B2
(en)
|
1999-05-10 |
2005-03-15 |
Barry M. Fell |
Surgically implantable knee prosthesis having different tibial and femoral surface profiles
|
US6911044B2
(en)
*
|
1999-05-10 |
2005-06-28 |
Barry M. Fell |
Surgically implantable knee prosthesis having medially shifted tibial surface
|
US6966928B2
(en)
|
1999-05-10 |
2005-11-22 |
Fell Barry M |
Surgically implantable knee prosthesis having keels
|
US6893463B2
(en)
*
|
1999-05-10 |
2005-05-17 |
Barry M. Fell |
Surgically implantable knee prosthesis having two-piece keyed components
|
US6855165B2
(en)
*
|
1999-05-10 |
2005-02-15 |
Barry M. Fell |
Surgically implantable knee prosthesis having enlarged femoral surface
|
US6923831B2
(en)
*
|
1999-05-10 |
2005-08-02 |
Barry M. Fell |
Surgically implantable knee prosthesis having attachment apertures
|
US6333020B1
(en)
|
1999-05-13 |
2001-12-25 |
Micro Therapeutics, Inc. |
Methods for treating AVM's using radio active compositions
|
US6241719B1
(en)
|
1999-05-13 |
2001-06-05 |
Micro Therapeutics, Inc. |
Method for forming a radioactive stent
|
EP1987847A1
(en)
|
1999-05-21 |
2008-11-05 |
Micro Therapeutics, Inc. |
Novel high viscosity embolizing compositions
|
EP1949890A3
(en)
|
1999-06-04 |
2011-05-18 |
ALZA Corporation |
Implantable gel compositions and method of manufacture
|
AU779277B2
(en)
*
|
1999-06-04 |
2005-01-13 |
Alza Corporation |
Implantable gel compositions and method of manufacture
|
DE60031114T2
(en)
*
|
1999-06-11 |
2007-05-03 |
Cytyc Corp., Marlborough |
LIQUID GEL FORMULATION FOR DETECTING MILK CHANNELS IN THE CHEST BEFORE SURGICAL ABLATION OF THE BREAST TISSUE
|
US6575991B1
(en)
|
1999-06-17 |
2003-06-10 |
Inrad, Inc. |
Apparatus for the percutaneous marking of a lesion
|
US6521431B1
(en)
*
|
1999-06-22 |
2003-02-18 |
Access Pharmaceuticals, Inc. |
Biodegradable cross-linkers having a polyacid connected to reactive groups for cross-linking polymer filaments
|
US6541020B1
(en)
*
|
1999-07-09 |
2003-04-01 |
Trimeris, Inc. |
Methods and compositions for administration of therapeutic reagents
|
US6179840B1
(en)
|
1999-07-23 |
2001-01-30 |
Ethicon, Inc. |
Graft fixation device and method
|
US20020095157A1
(en)
|
1999-07-23 |
2002-07-18 |
Bowman Steven M. |
Graft fixation device combination
|
US7008635B1
(en)
|
1999-09-10 |
2006-03-07 |
Genzyme Corporation |
Hydrogels for orthopedic repair
|
US7025980B1
(en)
|
1999-09-14 |
2006-04-11 |
Tepha, Inc. |
Polyhydroxyalkanoate compositions for soft tissue repair, augmentation, and viscosupplementation
|
US20020055708A1
(en)
*
|
1999-09-24 |
2002-05-09 |
Peterson Kenneth R. |
Coupling syringe system and methods for obtaining a mixed composition
|
US8226598B2
(en)
*
|
1999-09-24 |
2012-07-24 |
Tolmar Therapeutics, Inc. |
Coupling syringe system and methods for obtaining a mixed composition
|
ES2491866T3
(en)
*
|
1999-11-15 |
2014-09-08 |
Piramal Healthcare (Canada) Limited |
Temperature-controlled, pH-dependent, self-gelling aqueous biopolymer solution
|
US6461631B1
(en)
|
1999-11-16 |
2002-10-08 |
Atrix Laboratories, Inc. |
Biodegradable polymer composition
|
US6682754B2
(en)
*
|
1999-11-24 |
2004-01-27 |
Willmar Poultry Company, Inc. |
Ovo delivery of an immunogen containing implant
|
US20030158302A1
(en)
*
|
1999-12-09 |
2003-08-21 |
Cyric Chaput |
Mineral-polymer hybrid composition
|
AU1979201A
(en)
*
|
1999-12-09 |
2001-06-18 |
Bio Syntech Canada Inc |
Mineral-polymer hybrid composition
|
US20010037091A1
(en)
*
|
1999-12-29 |
2001-11-01 |
Wironen John F. |
System for reconstituting pastes and methods of using same
|
EP1248596B1
(en)
*
|
2000-01-11 |
2007-03-07 |
Roland Bodmeier |
Implantation kit comprising a support phase and a solvent
|
US7097855B1
(en)
*
|
2000-01-31 |
2006-08-29 |
Massachusetts Institute Of Technology |
Transdermal thermal polymerization
|
EP1257209A1
(en)
|
2000-02-10 |
2002-11-20 |
Harmonia Medical Technologies Inc. |
Transurethral volume reduction of the prostate (tuvor)
|
FI20000317A
(en)
*
|
2000-02-15 |
2001-08-16 |
Jvs Polymers Oy |
Biodegradable material
|
US6676971B2
(en)
|
2000-03-13 |
2004-01-13 |
Biocure, Inc. |
Embolic compositions
|
US6652883B2
(en)
*
|
2000-03-13 |
2003-11-25 |
Biocure, Inc. |
Tissue bulking and coating compositions
|
US6632246B1
(en)
|
2000-03-14 |
2003-10-14 |
Chondrosite, Llc |
Cartilage repair plug
|
US6626945B2
(en)
*
|
2000-03-14 |
2003-09-30 |
Chondrosite, Llc |
Cartilage repair plug
|
US7160931B2
(en)
*
|
2000-03-15 |
2007-01-09 |
Yu-Ling Cheng |
Thermally reversible implant and filler
|
US7193007B2
(en)
*
|
2000-03-15 |
2007-03-20 |
Yu-Ling Cheng |
Environment responsive gelling copolymer
|
US20030211974A1
(en)
*
|
2000-03-21 |
2003-11-13 |
Brodbeck Kevin J. |
Gel composition and methods
|
US6566144B1
(en)
|
2000-03-27 |
2003-05-20 |
Atrix Laboratories |
Cover plate for use in lyophilization
|
US6626870B1
(en)
|
2000-03-27 |
2003-09-30 |
Artix Laboratories, Inc. |
Stoppering method to maintain sterility
|
EP1142596A1
(en)
*
|
2000-04-03 |
2001-10-10 |
Universiteit Gent |
Compositions of crosslinkable prepolymers for use in therapeutically active biodegradable implants
|
AU5911101A
(en)
|
2000-04-19 |
2001-10-30 |
Genentech Inc |
Sustained release formulations
|
US6550482B1
(en)
*
|
2000-04-21 |
2003-04-22 |
Vascular Control Systems, Inc. |
Methods for non-permanent occlusion of a uterine artery
|
US6800671B1
(en)
|
2000-04-21 |
2004-10-05 |
Britesmile, Inc. |
Low peak exotherm curable compositions
|
US7018645B1
(en)
*
|
2000-04-27 |
2006-03-28 |
Macromed, Inc. |
Mixtures of various triblock polyester polyethylene glycol copolymers having improved gel properties
|
AU2001245346A1
(en)
*
|
2000-06-28 |
2002-01-08 |
Atul J. Shukla |
Biodegradable vehicles and delivery systems of biologically active substances
|
JP5089006B2
(en)
*
|
2000-06-29 |
2012-12-05 |
ピラマル ヘルスケア (カナダ) リミテッド |
Compositions and methods for repair and regeneration of cartilage and other tissues
|
GB0017999D0
(en)
*
|
2000-07-21 |
2000-09-13 |
Smithkline Beecham Biolog |
Novel device
|
DE10037983B4
(en)
*
|
2000-08-03 |
2006-04-13 |
Stefan Zikeli |
Polymer composition and molded articles containing it containing alkaloid
|
CA2420898A1
(en)
|
2000-08-28 |
2002-03-07 |
Advanced Bio Surfaces, Inc. |
Method for mammalian joint resurfacing
|
US6620196B1
(en)
*
|
2000-08-30 |
2003-09-16 |
Sdgi Holdings, Inc. |
Intervertebral disc nucleus implants and methods
|
DE10044545A1
(en)
*
|
2000-09-05 |
2002-04-04 |
Roland Bodmeier |
Retardpartikeldispersion
|
EP1315777B1
(en)
*
|
2000-09-06 |
2007-10-31 |
AP Pharma, Inc. |
Degradable polyacetal polymers
|
US7306591B2
(en)
|
2000-10-02 |
2007-12-11 |
Novasys Medical, Inc. |
Apparatus and methods for treating female urinary incontinence
|
AU2001296770A1
(en)
*
|
2000-10-06 |
2002-04-15 |
Durect Corporation |
Devices and methods for management of inflammation
|
WO2002030487A2
(en)
*
|
2000-10-11 |
2002-04-18 |
Micro Thereapeutics, Inc. |
Methods for treating aneurysms
|
US6565601B2
(en)
*
|
2000-11-15 |
2003-05-20 |
Micro Therapeutics, Inc. |
Methods for vascular reconstruction of diseased arteries
|
US20040091540A1
(en)
*
|
2000-11-15 |
2004-05-13 |
Desrosiers Eric Andre |
Method for restoring a damaged or degenerated intervertebral disc
|
US6726898B2
(en)
|
2000-11-17 |
2004-04-27 |
Gary R. Jernberg |
Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
|
US6576226B1
(en)
|
2000-11-17 |
2003-06-10 |
Gary R. Jernberg |
Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
|
US6648911B1
(en)
|
2000-11-20 |
2003-11-18 |
Avantec Vascular Corporation |
Method and device for the treatment of vulnerable tissue site
|
WO2002041786A2
(en)
*
|
2000-11-20 |
2002-05-30 |
Senorx, Inc. |
Tissue site markers for in vivo imaging
|
US20020106406A1
(en)
*
|
2000-12-08 |
2002-08-08 |
Mchugh Anthony J. |
Crystallizable/non-crystallizable polymer composites
|
US6599323B2
(en)
*
|
2000-12-21 |
2003-07-29 |
Ethicon, Inc. |
Reinforced tissue implants and methods of manufacture and use
|
CA2365376C
(en)
|
2000-12-21 |
2006-03-28 |
Ethicon, Inc. |
Use of reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
|
US6852330B2
(en)
*
|
2000-12-21 |
2005-02-08 |
Depuy Mitek, Inc. |
Reinforced foam implants with enhanced integrity for soft tissue repair and regeneration
|
US9080146B2
(en)
*
|
2001-01-11 |
2015-07-14 |
Celonova Biosciences, Inc. |
Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
|
DE60219433D1
(en)
*
|
2001-02-14 |
2007-05-24 |
Genzyme Corp |
BIOKOMPATIBLE LADIES FOR HEMOSTASIS AND TISSUE STRUCTURE
|
WO2002067991A1
(en)
*
|
2001-02-23 |
2002-09-06 |
Genentech, Inc. |
Erodible polymers for injection
|
US6913765B2
(en)
*
|
2001-03-21 |
2005-07-05 |
Scimed Life Systems, Inc. |
Controlling resorption of bioresorbable medical implant material
|
WO2002082973A2
(en)
*
|
2001-04-16 |
2002-10-24 |
Board Of Regents, The University Of Texas System |
Osteotropic biomaterials, methods of use thereof and implant systems incorporating the same
|
US6590059B2
(en)
*
|
2001-05-11 |
2003-07-08 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters from dioxolane-based diketene acetals
|
US20030152630A1
(en)
*
|
2001-05-11 |
2003-08-14 |
Ng Steven Y. |
PEG-POE, PEG-POE-PEG, and POE-PEG-POE block copolymers
|
US7455657B2
(en)
*
|
2001-06-19 |
2008-11-25 |
Boston Scientific Scimed, Inc |
Method and apparatus to modify a fluid using a selectively permeable membrane
|
US6730772B2
(en)
|
2001-06-22 |
2004-05-04 |
Venkatram P. Shastri |
Degradable polymers from derivatized ring-opened epoxides
|
GB0116341D0
(en)
*
|
2001-07-04 |
2001-08-29 |
Smith & Nephew |
Biodegradable polymer systems
|
US7345144B2
(en)
*
|
2001-07-11 |
2008-03-18 |
Palatin Technologies, Inc. |
Cyclic peptides for treatment of cachexia
|
US7342089B2
(en)
*
|
2001-07-11 |
2008-03-11 |
Palatin Technologies, Inc. |
Cyclic peptides for treatment for cachexia
|
US7105182B2
(en)
*
|
2001-07-25 |
2006-09-12 |
Szymaitis Dennis W |
Periodontal regeneration composition and method of using same
|
US20030026770A1
(en)
*
|
2001-07-25 |
2003-02-06 |
Szymaitis Dennis W. |
Periodontal regeneration composition and method of using same
|
US7456184B2
(en)
*
|
2003-05-01 |
2008-11-25 |
Palatin Technologies Inc. |
Melanocortin receptor-specific compounds
|
JP2005504043A
(en)
*
|
2001-08-10 |
2005-02-10 |
パラチン テクノロジーズ インク. |
Peptidomimetics of biologically active metal peptides
|
US7732451B2
(en)
*
|
2001-08-10 |
2010-06-08 |
Palatin Technologies, Inc. |
Naphthalene-containing melanocortin receptor-specific small molecule
|
US7718802B2
(en)
|
2001-08-10 |
2010-05-18 |
Palatin Technologies, Inc. |
Substituted melanocortin receptor-specific piperazine compounds
|
US7655658B2
(en)
*
|
2001-08-10 |
2010-02-02 |
Palatin Technologies, Inc. |
Thieno [2,3-D]pyrimidine-2,4-dione melanocortin-specific compounds
|
US20080063620A1
(en)
*
|
2001-08-13 |
2008-03-13 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Novel reverse thermo-sensitive block copolymers
|
US20030082235A1
(en)
*
|
2001-08-13 |
2003-05-01 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Novel reverse thermo-sensitive block copolymers
|
US20030060422A1
(en)
|
2001-08-31 |
2003-03-27 |
Balaji Venkataraman |
Tannate compositions and methods of treatment
|
US7309498B2
(en)
*
|
2001-10-10 |
2007-12-18 |
Belenkaya Bronislava G |
Biodegradable absorbents and methods of preparation
|
JP3993855B2
(en)
*
|
2001-11-01 |
2007-10-17 |
スパイン・ウェイブ・インコーポレーテッド |
Device for spinal disc recovery
|
EP1465521A4
(en)
|
2001-11-01 |
2008-10-08 |
Spine Wave Inc |
System and method for the pretreatment of the endplates of an intervertebral disc
|
US7488320B2
(en)
*
|
2001-11-01 |
2009-02-10 |
Renova Orthopedics, Llc |
Orthopaedic implant fixation using an in-situ formed anchor
|
DE60239556D1
(en)
*
|
2001-11-14 |
2011-05-05 |
Durect Corp |
CATHETERINJICIBLE DEPOT COMPOSITIONS AND THEIR USE
|
KR20040058100A
(en)
*
|
2001-11-14 |
2004-07-03 |
알자 코포레이션 |
Injectable depot compositions and uses thereof
|
US20070196415A1
(en)
*
|
2002-11-14 |
2007-08-23 |
Guohua Chen |
Depot compositions with multiple drug release rate controls and uses thereof
|
US6524606B1
(en)
*
|
2001-11-16 |
2003-02-25 |
Ap Pharma, Inc. |
Bioerodible polyorthoesters containing amine groups
|
GB2399309A
(en)
*
|
2001-12-19 |
2004-09-15 |
Advanced Bio Surfaces Inc |
Bone smoothing method and system
|
CA2469734A1
(en)
*
|
2002-01-14 |
2003-07-24 |
Micro Therapeutics, Inc. |
Methods for embolizing aneurysmal sites with a high viscosity embolizing composition
|
US20050058698A1
(en)
*
|
2002-01-21 |
2005-03-17 |
Nolan Yvonne Mairead |
Pharmaceutically acceptable phosphate-glycerol carrying bodies and uses relating to Parkinson's Disease
|
WO2003061522A2
(en)
*
|
2002-01-22 |
2003-07-31 |
Advanced Bio Surfaces, Inc. |
Interpositional arthroplasty system and method
|
GB0202233D0
(en)
*
|
2002-01-31 |
2002-03-20 |
Smith & Nephew |
Bioresorbable polymers
|
US8088388B2
(en)
*
|
2002-02-14 |
2012-01-03 |
United Biomedical, Inc. |
Stabilized synthetic immunogen delivery system
|
AU2003216379A1
(en)
*
|
2002-02-22 |
2003-09-09 |
Control Delivery Systems, Inc. |
Method for treating otic disorders
|
WO2003080629A2
(en)
|
2002-02-25 |
2003-10-02 |
Guilford Pharmaceuticals, Inc. |
Phosphorus-containing compounds with polymeric chains, and methods of making and using the same
|
CA2477535C
(en)
*
|
2002-02-28 |
2008-01-29 |
Wm. Marsh Rice University |
Pre-fabricated tissue-engineered plug
|
EP1344538A1
(en)
*
|
2002-03-14 |
2003-09-17 |
Degradable Solutions AG |
Porous biodegradable implant material and method for its fabrication
|
JP2005526079A
(en)
*
|
2002-03-15 |
2005-09-02 |
サイプレス バイオサイエンス, インコーポレイテッド |
NE and 5-HT reuptake inhibitors for treating visceral pain syndrome
|
WO2003080119A1
(en)
*
|
2002-03-26 |
2003-10-02 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Responsive biomedical composites
|
US20030203000A1
(en)
*
|
2002-04-24 |
2003-10-30 |
Schwarz Marlene C. |
Modulation of therapeutic agent release from a polymeric carrier using solvent-based techniques
|
US7432245B2
(en)
*
|
2002-06-07 |
2008-10-07 |
Abbott Laboratories Inc. |
Pharmaceutical formulation comprising a peptide angiogenesis inhibitor
|
US20030228365A1
(en)
*
|
2002-06-07 |
2003-12-11 |
Fortuna Haviv |
Pharmaceutical formulation
|
US7649023B2
(en)
*
|
2002-06-11 |
2010-01-19 |
Novartis Ag |
Biodegradable block copolymeric compositions for drug delivery
|
US20030228366A1
(en)
*
|
2002-06-11 |
2003-12-11 |
Chung Shih |
Reconstitutable compositions of biodegradable block copolymers
|
US7037983B2
(en)
*
|
2002-06-14 |
2006-05-02 |
Kimberly-Clark Worldwide, Inc. |
Methods of making functional biodegradable polymers
|
US20030232088A1
(en)
*
|
2002-06-14 |
2003-12-18 |
Kimberly-Clark Worldwide, Inc. |
Materials with both bioadhesive and biodegradable components
|
AR039729A1
(en)
|
2002-06-25 |
2005-03-09 |
Alza Corp |
SHORT-TERM DEPOSIT FORMULATIONS
|
US20080226723A1
(en)
*
|
2002-07-05 |
2008-09-18 |
Celonova Biosciences, Inc. |
Loadable Polymeric Particles for Therapeutic Use in Erectile Dysfunction and Methods of Preparing and Using the Same
|
US7160551B2
(en)
*
|
2002-07-09 |
2007-01-09 |
The Board Of Trustees Of The University Of Illinois |
Injectable system for controlled drug delivery
|
WO2004006811A2
(en)
*
|
2002-07-11 |
2004-01-22 |
Advanced Bio Surfaces, Inc. |
Method and kit for interpositional arthroplasty
|
EP1803399B1
(en)
*
|
2002-07-12 |
2010-12-29 |
MYCRONA Gesellschaft für innovative Messtechnik mbH |
Method and device for determining the current position of the structure of an object under investigation in a coordinates reference system
|
CA2494342A1
(en)
*
|
2002-07-31 |
2004-02-12 |
Alza Corporation |
Injectable depot compositions and uses thereof
|
DE60325742D1
(en)
|
2002-07-31 |
2009-02-26 |
Alza Corp |
INJECTABLE MULTIMODAL POLYMERS DEPOT COMPOSITIONS AND THEIR USES
|
US8062573B2
(en)
*
|
2002-09-16 |
2011-11-22 |
Theraject, Inc. |
Solid micro-perforators and methods of use
|
US6800663B2
(en)
*
|
2002-10-18 |
2004-10-05 |
Alkermes Controlled Therapeutics Inc. Ii, |
Crosslinked hydrogel copolymers
|
US20040078090A1
(en)
|
2002-10-18 |
2004-04-22 |
Francois Binette |
Biocompatible scaffolds with tissue fragments
|
US7824701B2
(en)
|
2002-10-18 |
2010-11-02 |
Ethicon, Inc. |
Biocompatible scaffold for ligament or tendon repair
|
US20040132826A1
(en)
*
|
2002-10-25 |
2004-07-08 |
Collegium Pharmaceutical, Inc. |
Modified release compositions of milnacipran
|
US20060003004A1
(en)
*
|
2002-10-25 |
2006-01-05 |
Collegium Pharmaceutical, Inc. |
Pulsatile release compositions of milnacipran
|
NZ539810A
(en)
*
|
2002-11-06 |
2008-03-28 |
Alza Corp |
Controlled release injectable depot formulations
|
PT1576138T
(en)
|
2002-11-15 |
2017-05-03 |
Idenix Pharmaceuticals Llc |
2'-methyl nucleosides in combination with interferon and flaviviridae mutation
|
US20060036158A1
(en)
*
|
2003-11-17 |
2006-02-16 |
Inrad, Inc. |
Self-contained, self-piercing, side-expelling marking apparatus
|
MXPA05008033A
(en)
*
|
2003-01-28 |
2006-04-28 |
Collegium Pharmaceutical Inc |
Multiparticulate compositions of milnacipran for oral administration.
|
US20040260398A1
(en)
*
|
2003-02-10 |
2004-12-23 |
Kelman David C. |
Resorbable devices
|
US20040197301A1
(en)
*
|
2003-02-18 |
2004-10-07 |
Zhong Zhao |
Hybrid polymers and methods of making the same
|
US20050025707A1
(en)
*
|
2003-02-27 |
2005-02-03 |
Patterson William R. |
Fumed silica embolic compositions
|
US8197837B2
(en)
|
2003-03-07 |
2012-06-12 |
Depuy Mitek, Inc. |
Method of preparation of bioabsorbable porous reinforced tissue implants and implants thereof
|
WO2004081196A2
(en)
*
|
2003-03-11 |
2004-09-23 |
Qlt Usa Inc. |
Formulations for cell- schedule dependent anticancer agents
|
US9445901B2
(en)
*
|
2003-03-12 |
2016-09-20 |
Deger C. Tunc |
Prosthesis with sustained release analgesic
|
US20060076295A1
(en)
*
|
2004-03-15 |
2006-04-13 |
The Trustees Of Columbia University In The City Of New York |
Systems and methods of blood-based therapies having a microfluidic membraneless exchange device
|
ATE510605T1
(en)
|
2003-03-14 |
2011-06-15 |
Univ Columbia |
SYSTEMS AND METHODS FOR BLOOD BASED THERAPY USING A MEMBRANELESS MICROFLUID EXCHANGE DEVICE
|
GB0307011D0
(en)
|
2003-03-27 |
2003-04-30 |
Regentec Ltd |
Porous matrix
|
DE10314082A1
(en)
*
|
2003-03-28 |
2004-10-21 |
Mcs Micro Carrier Systems Gmbh |
Biodegradable injectable implant
|
US20040202694A1
(en)
*
|
2003-04-11 |
2004-10-14 |
Vascular Control Systems, Inc. |
Embolic occlusion of uterine arteries
|
US8404269B2
(en)
*
|
2003-04-11 |
2013-03-26 |
Michael Snyder |
Sustained release implantable eye device
|
US7968548B2
(en)
|
2003-05-01 |
2011-06-28 |
Palatin Technologies, Inc. |
Melanocortin receptor-specific piperazine compounds with diamine groups
|
US7727990B2
(en)
|
2003-05-01 |
2010-06-01 |
Palatin Technologies, Inc. |
Melanocortin receptor-specific piperazine and keto-piperazine compounds
|
US7727991B2
(en)
|
2003-05-01 |
2010-06-01 |
Palatin Technologies, Inc. |
Substituted melanocortin receptor-specific single acyl piperazine compounds
|
WO2004101002A2
(en)
|
2003-05-08 |
2004-11-25 |
Tepha, Inc. |
Polyhydroxyalkanoate medical textiles and fibers
|
IL155866A0
(en)
*
|
2003-05-12 |
2003-12-23 |
Yissum Res Dev Co |
Responsive polymeric system
|
WO2004103342A2
(en)
*
|
2003-05-16 |
2004-12-02 |
Alkermes Controlled Therapeutics, Inc. |
Injectable sustained release compositions
|
US7877133B2
(en)
|
2003-05-23 |
2011-01-25 |
Senorx, Inc. |
Marker or filler forming fluid
|
AU2004245022A1
(en)
*
|
2003-05-30 |
2004-12-16 |
Alza Corporation |
Implantable elastomeric depot compositions, uses thereof and method of manufacturing
|
US20070184084A1
(en)
*
|
2003-05-30 |
2007-08-09 |
Guohua Chen |
Implantable elastomeric caprolactone depot compositions and uses thereof
|
US20060188573A1
(en)
*
|
2003-06-10 |
2006-08-24 |
Anna Imberg |
Composite materials and particles
|
WO2005002625A2
(en)
|
2003-06-26 |
2005-01-13 |
Control Delivery Systems, Inc. |
In-situ gelling drug delivery system
|
US8226715B2
(en)
|
2003-06-30 |
2012-07-24 |
Depuy Mitek, Inc. |
Scaffold for connective tissue repair
|
EP1651273B1
(en)
*
|
2003-07-08 |
2012-08-29 |
Tepha, Inc. |
Poly-4-hydroxybutyrate matrices for sustained drug delivery
|
EP2462923A3
(en)
|
2003-07-18 |
2012-08-29 |
Oakwood Laboratories L.L.C. |
Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions
|
US10583220B2
(en)
|
2003-08-11 |
2020-03-10 |
DePuy Synthes Products, Inc. |
Method and apparatus for resurfacing an articular surface
|
JP2007503221A
(en)
*
|
2003-08-22 |
2007-02-22 |
テファ, インコーポレイテッド |
Polyhydroxyalkanoate nerve regeneration device
|
US7141354B2
(en)
*
|
2003-09-30 |
2006-11-28 |
Dai Nippon Printing Co., Ltd. |
Photo radical generator, photo sensitive resin composition and article
|
US7309232B2
(en)
*
|
2003-10-10 |
2007-12-18 |
Dentigenix Inc. |
Methods for treating dental conditions using tissue scaffolds
|
US20050281879A1
(en)
*
|
2003-11-14 |
2005-12-22 |
Guohua Chen |
Excipients in drug delivery vehicles
|
US20050107867A1
(en)
*
|
2003-11-17 |
2005-05-19 |
Taheri Syde A. |
Temporary absorbable venous occlusive stent and superficial vein treatment method
|
US20050273002A1
(en)
*
|
2004-06-04 |
2005-12-08 |
Goosen Ryan L |
Multi-mode imaging marker
|
US8673021B2
(en)
|
2003-11-26 |
2014-03-18 |
Depuy Mitek, Llc |
Arthroscopic tissue scaffold delivery device
|
US7316822B2
(en)
|
2003-11-26 |
2008-01-08 |
Ethicon, Inc. |
Conformable tissue repair implant capable of injection delivery
|
US7901461B2
(en)
|
2003-12-05 |
2011-03-08 |
Ethicon, Inc. |
Viable tissue repair implants and methods of use
|
CA2552241C
(en)
*
|
2003-12-30 |
2013-10-01 |
Durect Corporation |
Co-polymeric devices for controlled release of active agents
|
KR20070006708A
(en)
*
|
2004-01-07 |
2007-01-11 |
트라이머리스 인코퍼레이티드 |
Hiv gp41 hr2-derived synthetic peptides, and their use in therapy to inhibit transmission of human immunodeficiency virus
|
TW200538148A
(en)
*
|
2004-01-13 |
2005-12-01 |
Vasogenix Pharmaceuticals Inc |
Methods for treating acute myocardial infarction by administering calcitonin gene related peptide and compositions containing the same
|
EP1703915A2
(en)
*
|
2004-01-13 |
2006-09-27 |
Vasogenix Pharmaceuticals, Inc. |
Methods of using cgrp for cardiovascular and renal indications
|
US20050165487A1
(en)
|
2004-01-28 |
2005-07-28 |
Muhanna Nabil L. |
Artificial intervertebral disc
|
US11395865B2
(en)
|
2004-02-09 |
2022-07-26 |
DePuy Synthes Products, Inc. |
Scaffolds with viable tissue
|
US9238127B2
(en)
|
2004-02-25 |
2016-01-19 |
Femasys Inc. |
Methods and devices for delivering to conduit
|
US8052669B2
(en)
|
2004-02-25 |
2011-11-08 |
Femasys Inc. |
Methods and devices for delivery of compositions to conduits
|
US8048101B2
(en)
|
2004-02-25 |
2011-11-01 |
Femasys Inc. |
Methods and devices for conduit occlusion
|
US8048086B2
(en)
|
2004-02-25 |
2011-11-01 |
Femasys Inc. |
Methods and devices for conduit occlusion
|
JP2007526085A
(en)
*
|
2004-03-02 |
2007-09-13 |
ナノセラピューティクス・インコーポレイテッド |
Compositions for repairing bone and methods for preparing and using such compositions
|
TW200533385A
(en)
*
|
2004-03-03 |
2005-10-16 |
Commw Scient Ind Res Org |
Biocompatible polymer compositions for dual or multi staged curing
|
US20050228433A1
(en)
*
|
2004-03-16 |
2005-10-13 |
Weenna Bucay-Couto |
In situ implant and method of forming same
|
US20050234336A1
(en)
*
|
2004-03-26 |
2005-10-20 |
Beckman Andrew T |
Apparatus and method for marking tissue
|
CA2563923A1
(en)
*
|
2004-04-15 |
2005-10-27 |
The University Of Utah Research Foundation |
Biodegradable and biocompatible peg-based poly(ester-urethanes)
|
US7709484B1
(en)
|
2004-04-19 |
2010-05-04 |
Palatin Technologies, Inc. |
Substituted melanocortin receptor-specific piperazine compounds
|
US8657881B2
(en)
|
2004-04-20 |
2014-02-25 |
Depuy Mitek, Llc |
Meniscal repair scaffold
|
US8221780B2
(en)
|
2004-04-20 |
2012-07-17 |
Depuy Mitek, Inc. |
Nonwoven tissue scaffold
|
US8137686B2
(en)
|
2004-04-20 |
2012-03-20 |
Depuy Mitek, Inc. |
Nonwoven tissue scaffold
|
US8163030B2
(en)
*
|
2004-05-06 |
2012-04-24 |
Degradable Solutions Ag |
Biocompatible bone implant compositions and methods for repairing a bone defect
|
US20050255045A1
(en)
*
|
2004-05-13 |
2005-11-17 |
Woltering Eugene A |
Surgical marking composition and method
|
WO2005115489A2
(en)
*
|
2004-05-24 |
2005-12-08 |
Genzyme Corporation |
Adherent polymeric compositions
|
US8142462B2
(en)
|
2004-05-28 |
2012-03-27 |
Cavitech, Llc |
Instruments and methods for reducing and stabilizing bone fractures
|
US7863406B2
(en)
*
|
2004-06-03 |
2011-01-04 |
Cornell Research Foundation, Inc. |
Unsaturated poly(ester-amide) biomaterials
|
US20110015367A1
(en)
*
|
2004-06-03 |
2011-01-20 |
Cornell University |
Unsaturated poly(ester-amide) and poly(ether ester amide) biomaterials
|
ATE401054T1
(en)
|
2004-06-04 |
2008-08-15 |
Camurus Ab |
LIQUID DEPOSIT FORMULATIONS
|
WO2005120462A2
(en)
*
|
2004-06-07 |
2005-12-22 |
Callisyn Pharmaceuticals, Inc. |
Biodegradable and biocompatible crosslinked polymer hydrogel prepared from pva and/or peg macromer mixtures
|
EP1604693A1
(en)
|
2004-06-09 |
2005-12-14 |
Scil Technology GmbH |
In situ forming scaffold, its manufacturing and use
|
WO2006004774A2
(en)
*
|
2004-06-28 |
2006-01-12 |
Stanford University |
Laulimalide analogues as therapeutic agents
|
JP4857268B2
(en)
*
|
2004-06-29 |
2012-01-18 |
バイオキュア・インコーポレーテッド |
Spinal disc nucleus pulposus graft
|
US7837733B2
(en)
|
2004-06-29 |
2010-11-23 |
Spine Wave, Inc. |
Percutaneous methods for injecting a curable biomaterial into an intervertebral space
|
JP2008505978A
(en)
*
|
2004-07-12 |
2008-02-28 |
アラーガン、インコーポレイテッド |
Ophthalmic composition and eye disease treatment method
|
ATE372772T1
(en)
|
2004-07-13 |
2007-09-15 |
Schering Oy |
RETARDED RELEASE SYSTEM WITH CONTROLLED INITIAL RELEASE
|
EP1778305B1
(en)
*
|
2004-08-03 |
2010-07-07 |
Tepha, Inc. |
Non-curling polyhydroxyalkanoate sutures
|
PT1786400E
(en)
*
|
2004-08-12 |
2009-06-19 |
Quest Pharmaceutical Services |
Pharmaceutical compositions for controlled release delivery of biologically active compounds
|
US20060039949A1
(en)
*
|
2004-08-20 |
2006-02-23 |
Nycz Jeffrey H |
Acetabular cup with controlled release of an osteoinductive formulation
|
WO2006026325A2
(en)
*
|
2004-08-26 |
2006-03-09 |
Pathak Chandrashekhar P |
Implantable tissue compositions and method
|
WO2006026504A2
(en)
*
|
2004-08-27 |
2006-03-09 |
Spherics, Inc. |
Mucoadhesive oral formulations of high permeability, high solubility drugs
|
US20060052822A1
(en)
*
|
2004-08-31 |
2006-03-09 |
Mirizzi Michael S |
Apparatus and material composition for permanent occlusion of a hollow anatomical structure
|
US20060045902A1
(en)
*
|
2004-09-01 |
2006-03-02 |
Serbousek Jon C |
Polymeric wrap for in vivo delivery of osteoinductive formulations
|
US8440215B2
(en)
*
|
2004-09-03 |
2013-05-14 |
Ethicon, Inc. |
Absorbable polymer formulations
|
US7754233B2
(en)
*
|
2004-09-03 |
2010-07-13 |
Ethicon, Inc. |
Method of preventing post-operative surgical adhesion
|
US20060057184A1
(en)
*
|
2004-09-16 |
2006-03-16 |
Nycz Jeffrey H |
Process to treat avascular necrosis (AVN) with osteoinductive materials
|
US20060074422A1
(en)
*
|
2004-09-27 |
2006-04-06 |
Story Brooks J |
Suture anchor and void filler combination
|
US9012506B2
(en)
|
2004-09-28 |
2015-04-21 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
US9801982B2
(en)
|
2004-09-28 |
2017-10-31 |
Atrium Medical Corporation |
Implantable barrier device
|
US9000040B2
(en)
|
2004-09-28 |
2015-04-07 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
EP1811933B1
(en)
|
2004-09-28 |
2016-03-23 |
Atrium Medical Corporation |
Barrier layer
|
US20060088596A1
(en)
|
2004-09-28 |
2006-04-27 |
Atrium Medical Corporation |
Solubilizing a drug for use in a coating
|
US8313763B2
(en)
*
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
CA2582374A1
(en)
*
|
2004-10-04 |
2006-04-20 |
Qlt Usa, Inc. |
Ocular delivery of polymeric delivery formulations
|
US9107850B2
(en)
*
|
2004-10-25 |
2015-08-18 |
Celonova Biosciences, Inc. |
Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
|
US20210299056A9
(en)
|
2004-10-25 |
2021-09-30 |
Varian Medical Systems, Inc. |
Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
|
KR101153785B1
(en)
*
|
2004-10-25 |
2012-07-09 |
셀로노바 바이오사이언시스 저머니 게엠베하 |
Loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
|
US9114162B2
(en)
*
|
2004-10-25 |
2015-08-25 |
Celonova Biosciences, Inc. |
Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
|
JP5244394B2
(en)
|
2004-11-10 |
2013-07-24 |
トルマー セラピューティクス, インコーポレイテッド. |
Stabilized polymer delivery system
|
AR052155A1
(en)
*
|
2004-12-14 |
2007-03-07 |
Novartis Ag |
ORGANIC COMPOUNDS
|
US20090292013A1
(en)
*
|
2004-12-14 |
2009-11-26 |
Caroline Sautter |
In-Situ Forming Implant for Animals
|
US20060282169A1
(en)
*
|
2004-12-17 |
2006-12-14 |
Felt Jeffrey C |
System and method for upper extremity joint arthroplasty
|
US20060142234A1
(en)
*
|
2004-12-23 |
2006-06-29 |
Guohua Chen |
Injectable non-aqueous suspension
|
EP1833430A2
(en)
*
|
2005-01-08 |
2007-09-19 |
Alphaspine, Inc. |
Modular disc device
|
US7728097B2
(en)
*
|
2005-01-10 |
2010-06-01 |
Ethicon, Inc. |
Method of making a diisocyanate terminated macromer
|
US8470954B2
(en)
|
2005-01-10 |
2013-06-25 |
Ethicon, Inc. |
Diisocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant
|
US20070167617A1
(en)
*
|
2006-01-17 |
2007-07-19 |
Fitz Benjamin D |
Method of making a diisocyanate terminated macromer
|
US20060153796A1
(en)
*
|
2005-01-10 |
2006-07-13 |
Fitz Benjamin D |
Diisocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant
|
US7968668B2
(en)
|
2005-01-10 |
2011-06-28 |
Ethicon Inc. |
Diisocyanate terminated macromer and formulation thereof for use as an internal adhesive or sealant
|
US9649382B2
(en)
|
2005-01-14 |
2017-05-16 |
Camurus Ab |
Topical bioadhesive formulations
|
DE602005026998D1
(en)
*
|
2005-01-14 |
2011-04-28 |
Camurus Ab |
SOMATOSTATIN-ANALOG FORMULATIONS
|
ES2458992T3
(en)
|
2005-01-14 |
2014-05-07 |
Camurus Ab |
GnRH analog formulations
|
AU2005325510B2
(en)
*
|
2005-01-21 |
2009-07-02 |
Camurus Ab |
Pharmaceutical lipid compositions
|
TW200635566A
(en)
|
2005-01-25 |
2006-10-16 |
Vnus Med Tech Inc |
Structures for permanent occlusion of a hollow anatomical structure
|
CA2596283C
(en)
*
|
2005-01-28 |
2011-11-01 |
Tepha, Inc. |
Embolization using poly-4-hydroxybutyrate particles
|
US8137664B2
(en)
*
|
2005-02-02 |
2012-03-20 |
Sdgi Holdings, Inc. |
Method and kit for repairing a defect in bone
|
US7611494B2
(en)
*
|
2005-02-08 |
2009-11-03 |
Confluent Surgical, Inc. |
Spray for fluent materials
|
EP1846505B1
(en)
*
|
2005-02-09 |
2015-11-11 |
Covidien LP |
Synthetic sealants
|
US20060182780A1
(en)
*
|
2005-02-16 |
2006-08-17 |
Riley Susan L |
Resorbable hollow devices for implantation and delivery of therapeutic agents
|
CA2498623A1
(en)
*
|
2005-02-18 |
2006-08-18 |
Qlt Inc. |
Treatment of onychomycosis
|
US20060189958A1
(en)
*
|
2005-02-21 |
2006-08-24 |
Talton James D |
Inverted cannula for use in reconstituting dry material in syringes
|
US7851189B2
(en)
*
|
2005-03-07 |
2010-12-14 |
Boston Scientific Scimed, Inc. |
Microencapsulated compositions for endoluminal tissue engineering
|
US7591853B2
(en)
*
|
2005-03-09 |
2009-09-22 |
Vertebral Technologies, Inc. |
Rail-based modular disc nucleus prosthesis
|
US20060222596A1
(en)
|
2005-04-01 |
2006-10-05 |
Trivascular, Inc. |
Non-degradable, low swelling, water soluble radiopaque hydrogel polymer
|
US10357328B2
(en)
*
|
2005-04-20 |
2019-07-23 |
Bard Peripheral Vascular, Inc. and Bard Shannon Limited |
Marking device with retractable cannula
|
US20060242562A1
(en)
*
|
2005-04-22 |
2006-10-26 |
Microsoft Corporation |
Embedded method for embedded interaction code array
|
US8414907B2
(en)
|
2005-04-28 |
2013-04-09 |
Warsaw Orthopedic, Inc. |
Coatings on medical implants to guide soft tissue healing
|
US9119901B2
(en)
*
|
2005-04-28 |
2015-09-01 |
Warsaw Orthopedic, Inc. |
Surface treatments for promoting selective tissue attachment to medical impants
|
US20080193543A1
(en)
*
|
2005-05-17 |
2008-08-14 |
Brown University Research Foundation |
Drug Delivery Formulations For Targeted Delivery
|
US9597352B2
(en)
*
|
2005-05-31 |
2017-03-21 |
Warsaw Orthopedic, Inc. |
Compositions and methods for treating pain
|
EP1888031B1
(en)
*
|
2005-06-06 |
2013-01-23 |
Camurus Ab |
Glp-1 analogue formulations
|
US7727235B2
(en)
*
|
2005-06-29 |
2010-06-01 |
Ethicon, Inc. |
Medical fixation devices with improved torsional drive head
|
ES2330716B1
(en)
*
|
2005-07-15 |
2010-07-09 |
Laboratorios Del Dr.Esteve, S.A. |
PHARMACEUTICAL FORMULATIONS OF SUBSTITUTED PIRAZOLINE COMPOUNDS.
|
EP1743638A1
(en)
|
2005-07-15 |
2007-01-17 |
Laboratorios Del Dr. Esteve, S.A. |
Pharmaceutical formulations of substituted pyrazoline compounds
|
CA2618404A1
(en)
*
|
2005-08-04 |
2007-02-15 |
Angiotech International Ag |
Block copolymer compositions and uses thereof
|
WO2007019578A2
(en)
|
2005-08-08 |
2007-02-15 |
Cytyc Corporation |
Tumescent skin spacing method
|
EP1922091A2
(en)
*
|
2005-08-18 |
2008-05-21 |
Smith & Nephew, PLC |
High strength devices and composites
|
US8362086B2
(en)
|
2005-08-19 |
2013-01-29 |
Merial Limited |
Long acting injectable formulations
|
GB0517673D0
(en)
*
|
2005-08-31 |
2005-10-05 |
Astrazeneca Ab |
Formulation
|
GB0517674D0
(en)
*
|
2005-08-31 |
2005-10-05 |
Astrazeneca Ab |
Formulation
|
ES2478623T3
(en)
*
|
2005-09-06 |
2014-07-22 |
Theraject, Inc. |
Solid solution perforator containing drug particles and / or drug adsorbent particles
|
US9427423B2
(en)
|
2009-03-10 |
2016-08-30 |
Atrium Medical Corporation |
Fatty-acid based particles
|
US9278161B2
(en)
|
2005-09-28 |
2016-03-08 |
Atrium Medical Corporation |
Tissue-separating fatty acid adhesion barrier
|
US10174070B2
(en)
|
2005-09-30 |
2019-01-08 |
Endece Llc |
6-substituted estradiol derivatives and methods of use
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
CA2562580C
(en)
|
2005-10-07 |
2014-04-29 |
Inrad, Inc. |
Drug-eluting tissue marker
|
WO2007142667A2
(en)
|
2005-10-13 |
2007-12-13 |
Human Genome Sciences, Inc. |
Treatment of patients with autoantibody positive disease
|
US20070166347A1
(en)
*
|
2005-10-13 |
2007-07-19 |
Endoluminal Therapeutics, Inc. |
Channeled endomural therapy
|
CA2626030A1
(en)
|
2005-10-15 |
2007-04-26 |
Atrium Medical Corporation |
Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
|
US20070100449A1
(en)
*
|
2005-10-31 |
2007-05-03 |
O'neil Michael |
Injectable soft tissue fixation technique
|
EP1948810A4
(en)
*
|
2005-11-04 |
2010-06-30 |
Biosyntech Canada Inc |
Composition and method for efficient delivery of nucleic acids to cells using chitosan
|
US20070110788A1
(en)
*
|
2005-11-14 |
2007-05-17 |
Hissong James B |
Injectable formulation capable of forming a drug-releasing device
|
US7754826B1
(en)
*
|
2005-11-15 |
2010-07-13 |
Clemson University |
Copolymers from lactide
|
CA2629300C
(en)
|
2005-11-17 |
2014-07-08 |
Zogenix, Inc. |
Delivery of viscous formulations by needle-free injection
|
US20070149641A1
(en)
*
|
2005-12-28 |
2007-06-28 |
Goupil Dennis W |
Injectable bone cement
|
EP1984009B1
(en)
|
2006-01-18 |
2012-10-24 |
Qps, Llc |
Pharmaceutical compositions with enhanced stability
|
ES2381631T3
(en)
|
2006-02-02 |
2012-05-30 |
Synageva Biopharma Corp. |
HIV fusion inhibitor peptides with improved biological properties
|
US8349443B2
(en)
*
|
2006-02-23 |
2013-01-08 |
Meadwestvaco Corporation |
Method for treating a substrate
|
WO2007103276A2
(en)
|
2006-03-03 |
2007-09-13 |
Smith & Nephew, Inc. |
Systems and methods for delivering a medicament
|
US8795709B2
(en)
*
|
2006-03-29 |
2014-08-05 |
Incept Llc |
Superabsorbent, freeze dried hydrogels for medical applications
|
US7795221B2
(en)
*
|
2006-03-30 |
2010-09-14 |
Palatin Technologies, Inc. |
Linear natriuretic peptide constructs
|
US8580746B2
(en)
|
2006-03-30 |
2013-11-12 |
Palatin Technologies, Inc. |
Amide linkage cyclic natriuretic peptide constructs
|
US7622440B2
(en)
|
2006-03-30 |
2009-11-24 |
Palatin Technologies, Inc. |
Cyclic natriuretic peptide constructs
|
US9017361B2
(en)
|
2006-04-20 |
2015-04-28 |
Covidien Lp |
Occlusive implant and methods for hollow anatomical structure
|
US7959943B2
(en)
*
|
2006-05-10 |
2011-06-14 |
Medtronics Xomed, Inc. |
Solvating system and sealant for medical use in the middle or inner ear
|
US7976873B2
(en)
*
|
2006-05-10 |
2011-07-12 |
Medtronic Xomed, Inc. |
Extracellular polysaccharide solvating system for treatment of bacterial ear conditions
|
US7993675B2
(en)
*
|
2006-05-10 |
2011-08-09 |
Medtronic Xomed, Inc. |
Solvating system and sealant for medical use in the sinuses and nasal passages
|
MX2008014732A
(en)
|
2006-05-22 |
2009-04-07 |
Univ Columbia |
Systems and methods of microfluidic membraneless exchange using filtration of extraction fluid outlet streams.
|
US7872068B2
(en)
*
|
2006-05-30 |
2011-01-18 |
Incept Llc |
Materials formable in situ within a medical device
|
DK2054073T3
(en)
*
|
2006-07-11 |
2015-03-02 |
Foresee Pharmaceuticals Inc |
Pharmaceutical compositions for sustained release of peptides
|
US7945307B2
(en)
*
|
2006-08-04 |
2011-05-17 |
Senorx, Inc. |
Marker delivery system with obturator
|
US20090171198A1
(en)
*
|
2006-08-04 |
2009-07-02 |
Jones Michael L |
Powdered marker
|
US7947758B2
(en)
*
|
2006-08-09 |
2011-05-24 |
Ethicon, Inc. |
Moisture activated latent curing adhesive or sealant
|
US8129445B2
(en)
*
|
2006-08-09 |
2012-03-06 |
Ethicon, Inc. |
Moisture activated latent curing adhesive or sealant
|
US7834017B2
(en)
|
2006-08-11 |
2010-11-16 |
Palatin Technologies, Inc. |
Diamine-containing, tetra-substituted piperazine compounds having identical 1- and 4-substituents
|
US20080058954A1
(en)
*
|
2006-08-22 |
2008-03-06 |
Hai Trieu |
Methods of treating spinal injuries using injectable flowable compositions comprising organic materials
|
US9744137B2
(en)
*
|
2006-08-31 |
2017-08-29 |
Supernus Pharmaceuticals, Inc. |
Topiramate compositions and methods of enhancing its bioavailability
|
US8076448B2
(en)
*
|
2006-10-11 |
2011-12-13 |
Tolmar Therapeutics, Inc. |
Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
|
ES2443526T3
(en)
|
2006-10-23 |
2014-02-19 |
C.R. Bard, Inc. |
Breast marker
|
US8268347B1
(en)
|
2006-10-24 |
2012-09-18 |
Aradigm Corporation |
Dual action, inhaled formulations providing both an immediate and sustained release profile
|
US20080102097A1
(en)
*
|
2006-10-31 |
2008-05-01 |
Zanella John M |
Device and method for treating osteolysis using a drug depot to deliver an anti-inflammatory agent
|
US9492596B2
(en)
|
2006-11-06 |
2016-11-15 |
Atrium Medical Corporation |
Barrier layer with underlying medical device and one or more reinforcing support structures
|
WO2008057328A2
(en)
|
2006-11-06 |
2008-05-15 |
Atrium Medical Corporation |
Tissue separating device with reinforced support for anchoring mechanisms
|
EP1973528B1
(en)
|
2006-11-17 |
2012-11-07 |
Supernus Pharmaceuticals, Inc. |
Sustained-release formulations of topiramate
|
US9737414B2
(en)
*
|
2006-11-21 |
2017-08-22 |
Vertebral Technologies, Inc. |
Methods and apparatus for minimally invasive modular interbody fusion devices
|
CA2679365C
(en)
|
2006-11-30 |
2016-05-03 |
Smith & Nephew, Inc. |
Fiber reinforced composite material
|
US7943683B2
(en)
*
|
2006-12-01 |
2011-05-17 |
Tepha, Inc. |
Medical devices containing oriented films of poly-4-hydroxybutyrate and copolymers
|
US9579077B2
(en)
*
|
2006-12-12 |
2017-02-28 |
C.R. Bard, Inc. |
Multiple imaging mode tissue marker
|
US20080140106A1
(en)
*
|
2006-12-12 |
2008-06-12 |
Kimberly-Clark Worldwide, Inc. |
Enhanced cuff sealing for endotracheal tubes
|
EP2101670B1
(en)
|
2006-12-18 |
2013-07-31 |
C.R.Bard, Inc. |
Biopsy marker with in situ-generated imaging properties
|
US8088095B2
(en)
*
|
2007-02-08 |
2012-01-03 |
Medtronic Xomed, Inc. |
Polymeric sealant for medical use
|
DK2115029T3
(en)
*
|
2007-02-15 |
2015-10-05 |
Tolmar Therapeutics Inc |
LAVSPRÆNGNING poly (lactide / glycolide) and methods to produce polymers
|
US20090227981A1
(en)
|
2007-03-05 |
2009-09-10 |
Bennett Steven L |
Low-Swelling Biocompatible Hydrogels
|
US20090227689A1
(en)
*
|
2007-03-05 |
2009-09-10 |
Bennett Steven L |
Low-Swelling Biocompatible Hydrogels
|
US20080220047A1
(en)
|
2007-03-05 |
2008-09-11 |
Sawhney Amarpreet S |
Low-swelling biocompatible hydrogels
|
BRPI0809995A2
(en)
*
|
2007-04-03 |
2015-07-21 |
Trimeris Inc |
Composition, and methods for sustained release of a peptide in a patient and for ameliorating a symptom associated with an HIV infection.
|
CA2684759C
(en)
|
2007-05-15 |
2015-11-03 |
Barry M. Fell |
Surgically implantable knee prosthesis with captured keel
|
ES2606951T3
(en)
|
2007-05-18 |
2017-03-28 |
Durect Corporation |
Enhanced extended release formulations
|
US20080294167A1
(en)
|
2007-05-21 |
2008-11-27 |
Brian Schumacher |
Articulating cavitation device
|
CN101801415B
(en)
|
2007-05-25 |
2015-09-23 |
Rb医药品有限公司 |
The sustained delivery formulations of risperidone compounds
|
US20100204432A1
(en)
*
|
2007-05-28 |
2010-08-12 |
Husam Younes |
Biodegradable elastomers prepared by the condensation of an organic di-, tri- or tetra-carboxylic acid and an organic diol
|
CN201075472Y
(en)
*
|
2007-05-28 |
2008-06-18 |
富士康(昆山)电脑接插件有限公司 |
Electric Connector
|
GB0711656D0
(en)
*
|
2007-06-15 |
2007-07-25 |
Camurus Ab |
Formulations
|
US9125807B2
(en)
*
|
2007-07-09 |
2015-09-08 |
Incept Llc |
Adhesive hydrogels for ophthalmic drug delivery
|
US20090149569A1
(en)
*
|
2007-07-19 |
2009-06-11 |
Shastri V Prasad |
Surface engineering of tissue graft materials for enhanced porosity and cell adhesion
|
US7850453B2
(en)
*
|
2007-08-08 |
2010-12-14 |
Coll Partners Ltd. |
Reshapable device for fixation at a dental site
|
US8067028B2
(en)
*
|
2007-08-13 |
2011-11-29 |
Confluent Surgical Inc. |
Drug delivery device
|
GB0716385D0
(en)
|
2007-08-22 |
2007-10-03 |
Camurus Ab |
Formulations
|
EP2205193A2
(en)
*
|
2007-09-07 |
2010-07-14 |
QLT Plug Delivery, Inc. |
Lacrimal implant detection
|
KR20100080812A
(en)
*
|
2007-09-25 |
2010-07-12 |
트라이머리스, 인코퍼레이티드 |
Methods of synthesis for therapeuthic anti-hiv peptides
|
US20090088723A1
(en)
*
|
2007-09-28 |
2009-04-02 |
Accessclosure, Inc. |
Apparatus and methods for treating pseudoaneurysms
|
US8703119B2
(en)
*
|
2007-10-05 |
2014-04-22 |
Polygene Ltd. |
Injectable biodegradable polymer compositions for soft tissue repair and augmentation
|
ES2528409T3
(en)
|
2007-10-24 |
2015-02-10 |
Camurus Ab |
Controlled Release Formulations
|
US20090110738A1
(en)
*
|
2007-10-26 |
2009-04-30 |
Celonova Biosciences, Inc. |
Loadable Polymeric Particles for Cosmetic and Reconstructive Tissue Augmentation Applications and Methods of Preparing and Using the Same
|
US20090111763A1
(en)
*
|
2007-10-26 |
2009-04-30 |
Celonova Biosciences, Inc. |
Loadable polymeric particles for bone augmentation and methods of preparing and using the same
|
US20090110730A1
(en)
*
|
2007-10-30 |
2009-04-30 |
Celonova Biosciences, Inc. |
Loadable Polymeric Particles for Marking or Masking Individuals and Methods of Preparing and Using the Same
|
US20090110731A1
(en)
*
|
2007-10-30 |
2009-04-30 |
Celonova Biosciences, Inc. |
Loadable Polymeric Microparticles for Therapeutic Use in Alopecia and Methods of Preparing and Using the Same
|
CA2705520C
(en)
*
|
2007-11-13 |
2016-06-28 |
Surmodics Pharmaceuticals, Inc. |
Viscous terpolymers as drug delivery platform
|
AT506168B1
(en)
*
|
2007-11-23 |
2012-02-15 |
Univ Wien Tech |
USE OF COMPOSITIONS FOR THE MANUFACTURE OF BIODEGRADABLE, BIOVEROUS, NETWORKED POLYMERS BASED ON POLYVINYL ALCOHOL
|
CA2710515A1
(en)
*
|
2007-12-28 |
2009-07-09 |
Khashayar Kevin Neshat |
Controlled release local anesthetic for post dental surgery and method of use
|
US20090181068A1
(en)
*
|
2008-01-14 |
2009-07-16 |
Dunn Richard L |
Low Viscosity Liquid Polymeric Delivery System
|
SG10201906494PA
(en)
|
2008-01-30 |
2019-09-27 |
Histogen Inc |
Extracellular matrix compositions
|
WO2009099767A2
(en)
*
|
2008-01-31 |
2009-08-13 |
C.R. Bard, Inc. |
Biopsy tissue marker
|
CA2714594A1
(en)
|
2008-02-04 |
2009-08-13 |
Edward F. Leonard |
Fluid separation devices, systems and methods
|
US20090202642A1
(en)
*
|
2008-02-08 |
2009-08-13 |
Xiao Huang |
Drug Delivery System Comprising Microparticles and Gelation System
|
US9107815B2
(en)
|
2008-02-22 |
2015-08-18 |
Allergan, Inc. |
Sustained release poloxamer containing pharmaceutical compositions
|
US8071663B2
(en)
*
|
2008-02-29 |
2011-12-06 |
Ethicon, Inc. |
Medically acceptable formulation of a diisocyanate terminated macromer for use as an internal adhesive or sealant
|
US8324292B2
(en)
*
|
2008-02-29 |
2012-12-04 |
Ethicon, Inc. |
Medically acceptable formulation of a diisocyanate terminated macromer for use as an internal adhesive or sealant
|
US8745133B2
(en)
*
|
2008-03-28 |
2014-06-03 |
Yahoo! Inc. |
System and method for optimizing the storage of data
|
RU2499592C2
(en)
|
2008-04-21 |
2013-11-27 |
Отономи, Инк. |
Pharmaceutical composition for treating ear diseases
|
AU2009241847B2
(en)
|
2008-04-28 |
2014-07-10 |
Zogenix, Inc. |
Novel formulations for treatment of migraine
|
US20110125158A1
(en)
|
2008-05-01 |
2011-05-26 |
Ashish Dhar Diwan |
Systems, methods and apparatuses for formation and insertion of tissue prostheses
|
WO2009139924A2
(en)
|
2008-05-14 |
2009-11-19 |
Otonomy, Inc. |
Controlled release corticosteroid compositions and methods for the treatment of otic disorders
|
US9381680B2
(en)
*
|
2008-05-21 |
2016-07-05 |
Theraject, Inc. |
Method of manufacturing solid solution perforator patches and uses thereof
|
WO2009148579A2
(en)
|
2008-06-03 |
2009-12-10 |
Qlt Usa, Inc. |
Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system
|
US8877225B2
(en)
*
|
2008-06-03 |
2014-11-04 |
Tolmar Therapeutics, Inc. |
Controlled release copolymer formulation with improved release kinetics
|
CA2727432C
(en)
|
2008-06-12 |
2016-10-11 |
Medtronic Xomed, Inc. |
Method for treating chronic wounds with an extracellular polymeric substance solvating system
|
AU2009270695A1
(en)
|
2008-07-17 |
2010-01-21 |
Ap Pharma |
Methods for enhancing the stability of polyorthoesters and their formulations
|
US8318817B2
(en)
|
2008-07-21 |
2012-11-27 |
Otonomy, Inc. |
Controlled release antimicrobial compositions and methods for the treatment of otic disorders
|
WO2010011605A2
(en)
|
2008-07-21 |
2010-01-28 |
Otonomy, Inc. |
Controlled-release otic structure modulating and innate immune system modulating compositions and methods for the treatment of otic disorders
|
US8784870B2
(en)
|
2008-07-21 |
2014-07-22 |
Otonomy, Inc. |
Controlled release compositions for modulating free-radical induced damage and methods of use thereof
|
AU2009277252B2
(en)
|
2008-07-30 |
2014-01-16 |
Mesynthes Limited |
Tissue scaffolds derived from forestomach extracellular matrix
|
US9271706B2
(en)
*
|
2008-08-12 |
2016-03-01 |
Covidien Lp |
Medical device for wound closure and method of use
|
WO2010022180A1
(en)
|
2008-08-19 |
2010-02-25 |
Micro Therapeutics, Inc. |
Detachable tip microcatheter
|
GB0815435D0
(en)
|
2008-08-22 |
2008-10-01 |
Camurus Ab |
Formulations
|
US9327061B2
(en)
|
2008-09-23 |
2016-05-03 |
Senorx, Inc. |
Porous bioabsorbable implant
|
EP2341923A2
(en)
*
|
2008-09-26 |
2011-07-13 |
Saumya Sharma |
Pharmaceutical composition comprising coenzyme q10
|
US10070888B2
(en)
|
2008-10-03 |
2018-09-11 |
Femasys, Inc. |
Methods and devices for sonographic imaging
|
US9554826B2
(en)
|
2008-10-03 |
2017-01-31 |
Femasys, Inc. |
Contrast agent injection system for sonographic imaging
|
US9889230B2
(en)
*
|
2008-10-17 |
2018-02-13 |
Covidien Lp |
Hemostatic implant
|
ES2549158T3
(en)
|
2008-11-11 |
2015-10-23 |
Signum Biosciences, Inc. |
Isoprenyl compounds and methods thereof
|
US8822546B2
(en)
*
|
2008-12-01 |
2014-09-02 |
Medtronic, Inc. |
Flowable pharmaceutical depot
|
WO2010065801A1
(en)
|
2008-12-04 |
2010-06-10 |
Palatin Technologies, Inc. |
Amine substituted piperazine melanocortin receptor-specific compounds
|
WO2010065799A2
(en)
|
2008-12-04 |
2010-06-10 |
Palatin Technologies, Inc. |
Amine substituted piperidine melanocortin receptor-specific compounds
|
WO2010065802A2
(en)
|
2008-12-04 |
2010-06-10 |
Palatin Technologies, Inc. |
Substituted pyrrolidine or imidazolidine melanocortin receptor-specific compounds
|
US9480643B2
(en)
|
2008-12-23 |
2016-11-01 |
Surmodics Pharmaceuticals, Inc. |
Implantable composites and implants comprising same
|
US20100168807A1
(en)
*
|
2008-12-23 |
2010-07-01 |
Burton Kevin W |
Bioactive terpolymer compositions and methods of making and using same
|
US9415197B2
(en)
*
|
2008-12-23 |
2016-08-16 |
Surmodics, Inc. |
Implantable suction cup composites and implants comprising same
|
US8951546B2
(en)
|
2008-12-23 |
2015-02-10 |
Surmodics Pharmaceuticals, Inc. |
Flexible implantable composites and implants comprising same
|
US8974808B2
(en)
|
2008-12-23 |
2015-03-10 |
Surmodics, Inc. |
Elastic implantable composites and implants comprising same
|
WO2010077244A1
(en)
*
|
2008-12-30 |
2010-07-08 |
C.R. Bard Inc. |
Marker delivery device for tissue marker placement
|
US8469779B1
(en)
|
2009-01-02 |
2013-06-25 |
Lifecell Corporation |
Method for debristling animal skin
|
WO2010079340A2
(en)
|
2009-01-08 |
2010-07-15 |
Eisai R & D Management Co., Ltd. |
Assay
|
EP2210589B1
(en)
*
|
2009-01-22 |
2015-05-06 |
Ludwig-Maximilians-Universität München |
Vesicular phospholipid gels comprising proteinaceous substances
|
US20100204570A1
(en)
*
|
2009-02-06 |
2010-08-12 |
Paul Lubock |
Anchor markers
|
WO2010093873A2
(en)
|
2009-02-12 |
2010-08-19 |
Incept, Llc |
Drug delivery through hydrogel plugs
|
WO2010093993A2
(en)
|
2009-02-12 |
2010-08-19 |
Human Genome Sciences, Inc. |
Use of b lymphocyte stimulator protein antagonists to promote transplantation tolerance
|
WO2010094032A2
(en)
|
2009-02-16 |
2010-08-19 |
Aoi Medical Inc. |
Trauma nail accumulator
|
EP2223707B1
(en)
*
|
2009-02-26 |
2014-04-09 |
New Dent AG |
Implant system and bone implant
|
US8383140B2
(en)
*
|
2009-04-03 |
2013-02-26 |
Poly-Med, Inc. |
Absorbable crystalline copolyester-based bioactive hydroforming luminal liner compositions
|
US9433700B2
(en)
|
2009-04-27 |
2016-09-06 |
Medibeacon Inc. |
Tissue sealant compositions, vascular closure devices, and uses thereof
|
CA2760704C
(en)
*
|
2009-05-04 |
2017-10-03 |
Incept, Llc |
Biomaterials for track and puncture closure
|
AU2010259008C1
(en)
|
2009-06-08 |
2016-04-21 |
Palatin Technologies, Inc. |
Melanocortin receptor-specific peptides
|
US20120108514A1
(en)
|
2009-07-09 |
2012-05-03 |
University Of Iowa Research Foundation |
Long acting atrial natriuretic peptide (la-anp) and methods for use thereof
|
US20110015672A1
(en)
*
|
2009-07-17 |
2011-01-20 |
Tyco Healthcare Group Lp |
Method for Coating a Medical Device
|
US9200112B2
(en)
|
2009-08-10 |
2015-12-01 |
Ethicon, Inc. |
Semi-crystalline, fast absorbing polymer formulation
|
US20110038910A1
(en)
|
2009-08-11 |
2011-02-17 |
Atrium Medical Corporation |
Anti-infective antimicrobial-containing biomaterials
|
FR2949687B1
(en)
|
2009-09-04 |
2011-09-23 |
Sofradim Production |
FABRIC WITH PICOTS COATED WITH WATER-SOLUBLE MATERIAL
|
US8470355B2
(en)
*
|
2009-10-01 |
2013-06-25 |
Covidien Lp |
Mesh implant
|
US8138236B2
(en)
*
|
2009-10-29 |
2012-03-20 |
Ethicon, Inc. |
Solvent-free moisture activated latent curing surgical adhesive or sealant
|
US9044524B2
(en)
*
|
2009-10-30 |
2015-06-02 |
Ethicon, Inc. |
Absorbable polyethylene diglycolate copolymers to reduce microbial adhesion to medical devices and implants
|
JP2013509963A
(en)
|
2009-11-09 |
2013-03-21 |
スポットライト テクノロジー パートナーズ エルエルシー |
Fragmented hydrogel
|
WO2011057131A1
(en)
|
2009-11-09 |
2011-05-12 |
Spotlight Technology Partners Llc |
Polysaccharide based hydrogels
|
CN102655745B
(en)
|
2009-11-12 |
2016-01-06 |
西格纳姆生物科学公司 |
Antibacterial agent is used for the treatment of the purposes of epithelial-related disease condition
|
WO2011084465A2
(en)
|
2009-12-15 |
2011-07-14 |
Incept, Llc |
Implants and biodegradable fiducial markers
|
GB0922438D0
(en)
|
2009-12-22 |
2010-02-03 |
Ucl Business Plc |
Agents having tissue generative activity
|
US20110218606A1
(en)
*
|
2010-03-02 |
2011-09-08 |
Medtronic Vascular, Inc. |
Methods for Stabilizing Femoral Vessels
|
US20120130489A1
(en)
*
|
2010-05-19 |
2012-05-24 |
Chernomorsky Ary S |
Methods and apparatus for in situ formation of surgical implants
|
EP2571383B1
(en)
|
2010-05-20 |
2022-01-26 |
Ecolab USA Inc. |
Rheology modified low foaming liquid antimicrobial compositions and methods of use thereof
|
US10335366B2
(en)
|
2010-05-31 |
2019-07-02 |
Laboratorios Farmacéuticos Rovi, S.A. |
Risperidone or paliperidone implant formulation
|
US10285936B2
(en)
|
2010-05-31 |
2019-05-14 |
Laboratorios Farmacéuticos Rovi, S.A. |
Injectable composition with aromatase inhibitor
|
US10350159B2
(en)
|
2010-05-31 |
2019-07-16 |
Laboratories Farmacéuticos Rovi, S.A. |
Paliperidone implant formulation
|
US10881605B2
(en)
|
2010-05-31 |
2021-01-05 |
Laboratorios Farmaceuticos Rovi, S.A. |
Methods for the preparation of injectable depot compositions
|
PT2394664T
(en)
|
2010-05-31 |
2016-09-06 |
Farm Rovi Lab Sa |
Antipsychotic injectable depot composition
|
US10463607B2
(en)
|
2010-05-31 |
2019-11-05 |
Laboratorios Farmaceutics Rofi S.A. |
Antipsychotic Injectable Depot Composition
|
HRP20211853T1
(en)
|
2010-05-31 |
2022-03-04 |
Laboratorios Farmaceuticos Rovi, S.A. |
Compositions for injectable in-situ biodegradable implants
|
GB2481017B
(en)
|
2010-06-08 |
2015-01-07 |
Rb Pharmaceuticals Ltd |
Microparticle buprenorphine suspension
|
US9272044B2
(en)
|
2010-06-08 |
2016-03-01 |
Indivior Uk Limited |
Injectable flowable composition buprenorphine
|
GB2513267B
(en)
|
2010-06-08 |
2015-03-18 |
Rb Pharmaceuticals Ltd |
Injectable flowable composition comprising buprenorphine
|
US9364518B2
(en)
|
2010-06-24 |
2016-06-14 |
Torrent Pharmaceuticals Limited |
Pharmaceutical composition containing goserelin for in-situ implant
|
US9232805B2
(en)
|
2010-06-29 |
2016-01-12 |
Biocure, Inc. |
In-situ forming hydrogel wound dressings containing antimicrobial agents
|
EP2593141B1
(en)
|
2010-07-16 |
2018-07-04 |
Atrium Medical Corporation |
Composition and methods for altering the rate of hydrolysis of cured oil-based materials
|
WO2012030822A1
(en)
|
2010-08-30 |
2012-03-08 |
Surmodics Pharmaceuticals, Inc. |
Process for reducing moisture in a biodegradable implant device
|
US8961501B2
(en)
|
2010-09-17 |
2015-02-24 |
Incept, Llc |
Method for applying flowable hydrogels to a cornea
|
GB201016436D0
(en)
|
2010-09-30 |
2010-11-17 |
Q Chip Ltd |
Method of making solid beads
|
GB201016433D0
(en)
|
2010-09-30 |
2010-11-17 |
Q Chip Ltd |
Apparatus and method for making solid beads
|
US9320601B2
(en)
|
2011-10-20 |
2016-04-26 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants
|
US11058796B2
(en)
|
2010-10-20 |
2021-07-13 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
|
US11207109B2
(en)
|
2010-10-20 |
2021-12-28 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
|
US10525169B2
(en)
|
2010-10-20 |
2020-01-07 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
|
US11291483B2
(en)
|
2010-10-20 |
2022-04-05 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants
|
WO2015095745A1
(en)
|
2010-10-20 |
2015-06-25 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
|
US11484627B2
(en)
|
2010-10-20 |
2022-11-01 |
206 Ortho, Inc. |
Method and apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone, including the provision and use of composite implants, and novel composite structures which may be used for medical and non-medical applications
|
WO2012054742A2
(en)
*
|
2010-10-20 |
2012-04-26 |
BIOS2 Medical, Inc. |
Implantable polymer for bone and vascular lesions
|
US8740982B2
(en)
*
|
2010-10-26 |
2014-06-03 |
Kyphon Sarl |
Devices containing a chemonucleolysis agent and methods for treating an intervertebral disc or spinal arachnoiditis
|
US9414930B2
(en)
*
|
2010-10-26 |
2016-08-16 |
Kyphon SÀRL |
Activatable devices containing a chemonucleolysis agent
|
SG191414A1
(en)
|
2010-12-29 |
2013-08-30 |
Medincell |
Biodegradable drug delivery compositions
|
US9084602B2
(en)
|
2011-01-26 |
2015-07-21 |
Covidien Lp |
Buttress film with hemostatic action for surgical stapling apparatus
|
US9447187B2
(en)
|
2011-02-03 |
2016-09-20 |
Alexion Pharmaceuticals, Inc. |
Use of an anti-CD200 antibody for prolonging the survival of allografts
|
BR112013026200A2
(en)
|
2011-04-14 |
2019-08-27 |
Lifecell Corp |
method for preparing a fabric matrix, and tissue matrix composition
|
US9757388B2
(en)
|
2011-05-13 |
2017-09-12 |
Acerus Pharmaceuticals Srl |
Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
|
AR082266A1
(en)
|
2011-05-13 |
2012-11-28 |
Univ Nac Del Litoral |
INJECTABLE CONTROLLED LIBERATION MICROPARTICLE
|
US20130045958A1
(en)
|
2011-05-13 |
2013-02-21 |
Trimel Pharmaceuticals Corporation |
Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
|
AR086400A1
(en)
|
2011-05-13 |
2013-12-11 |
Trimel Pharmaceuticals Corp |
FORMULATIONS IN INTRANASAL GEL OF TESTOSTERONE IN DOSE OF LOWER POWER AND USE OF THE SAME FOR THE TREATMENT OF ANORGASMIA OR THE DISORDER OF HYPOACTIVE SEXUAL DESIRE
|
WO2012177759A1
(en)
|
2011-06-20 |
2012-12-27 |
Rdc Holdings, Llc |
System and method for repairing joints
|
US8998925B2
(en)
|
2011-06-20 |
2015-04-07 |
Rdc Holdings, Llc |
Fixation system for orthopedic devices
|
US9326951B2
(en)
|
2011-06-28 |
2016-05-03 |
Yale University |
Cell-free tissue engineered vascular grafts
|
US9089523B2
(en)
|
2011-07-28 |
2015-07-28 |
Lifecell Corporation |
Natural tissue scaffolds as tissue fillers
|
CN107090028A
(en)
|
2011-08-30 |
2017-08-25 |
梅约医学教育与研究基金会 |
Sharp sodium polypeptide
|
US10226417B2
(en)
|
2011-09-16 |
2019-03-12 |
Peter Jarrett |
Drug delivery systems and applications
|
DE102011114986A1
(en)
*
|
2011-09-28 |
2013-03-28 |
Ethris Gmbh |
spray system
|
US8586527B2
(en)
|
2011-10-20 |
2013-11-19 |
Jaipal Singh |
Cerivastatin to treat pulmonary disorders
|
WO2013078422A2
(en)
|
2011-11-23 |
2013-05-30 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
MX2014006479A
(en)
|
2011-11-30 |
2015-01-22 |
Univ Emory |
Antiviral jak inhibitors useful in treating or preventing retroviral and other viral infections.
|
CN104105479B
(en)
|
2011-12-05 |
2018-04-10 |
卡穆鲁斯公司 |
Robustness controlled release preparation
|
US9205150B2
(en)
|
2011-12-05 |
2015-12-08 |
Incept, Llc |
Medical organogel processes and compositions
|
US9115066B2
(en)
|
2011-12-14 |
2015-08-25 |
Indicator Systems International, Inc. |
Trisubstituted methyl alcohols and their polymerizable derivatives
|
EP3549615B1
(en)
|
2011-12-20 |
2020-12-16 |
LifeCell Corporation |
Sheet tissue products
|
DK2793965T3
(en)
|
2011-12-20 |
2019-05-20 |
Lifecell Corp |
TISSUE PRODUCTS WITH FLYING DUTIES
|
WO2013103896A1
(en)
|
2012-01-06 |
2013-07-11 |
Mayo Foundation For Medical Education And Research |
Treating cardiovascular or renal diseases
|
RU2019104004A
(en)
|
2012-01-23 |
2019-03-07 |
Сейдж Терапьютикс, Инк. |
MEDICINAL FORMS OF NEUROACTIVE STEROIDS AND METHODS OF TREATING CNS DISORDERS
|
WO2013112350A1
(en)
|
2012-01-24 |
2013-08-01 |
Lifecell Corporation |
Elongated tissue matrices
|
US9534018B2
(en)
|
2012-03-13 |
2017-01-03 |
Tensive Controls Inc. |
Melanocortin analogs having enhanced activity and transport
|
US9510953B2
(en)
|
2012-03-16 |
2016-12-06 |
Vertebral Technologies, Inc. |
Modular segmented disc nucleus implant
|
US8403927B1
(en)
|
2012-04-05 |
2013-03-26 |
William Bruce Shingleton |
Vasectomy devices and methods
|
US8753643B1
(en)
|
2012-04-11 |
2014-06-17 |
Life-Science Innovations, Llc |
Spray dried compositions and methods of use
|
WO2013163186A1
(en)
|
2012-04-24 |
2013-10-31 |
Lifecell Corporation |
Flowable tissue matrices
|
NL2008861C2
(en)
*
|
2012-05-23 |
2013-11-26 |
Urogyn B V |
Composition for soft tissue treatment.
|
WO2013174978A1
(en)
|
2012-05-25 |
2013-11-28 |
Camurus Ab |
Somatostatin receptor agonist formulations
|
CN110664816A
(en)
|
2012-06-07 |
2020-01-10 |
佐治亚州立大学研究基金会公司 |
SECA inhibitors and methods of making and using the same
|
US9867880B2
(en)
|
2012-06-13 |
2018-01-16 |
Atrium Medical Corporation |
Cured oil-hydrogel biomaterial compositions for controlled drug delivery
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11090338B2
(en)
|
2012-07-13 |
2021-08-17 |
Lifecell Corporation |
Methods for improved treatment of adipose tissue
|
US9937164B2
(en)
|
2012-07-26 |
2018-04-10 |
Camurus Ab |
Opioid formulations
|
EP2887944B1
(en)
|
2012-08-21 |
2021-10-06 |
Sage Therapeutics, Inc. |
Allopregnanolone for treating refractory status epilepticus
|
WO2014052376A1
(en)
|
2012-09-26 |
2014-04-03 |
Lifecell Corporation |
Processed adipose tissue
|
RU2768868C2
(en)
|
2012-09-27 |
2022-03-25 |
Дзе Чилдрен'З Медикал Сентер Корпорейшн |
Compounds for treating obesity, and methods for using them
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
CN104994893B
(en)
|
2013-02-06 |
2018-01-05 |
生命细胞公司 |
Method for the partial modification of tissue products
|
CN109602692B
(en)
|
2013-03-11 |
2022-11-04 |
度瑞公司 |
Injectable controlled release compositions comprising high viscosity liquid carriers
|
US20140308352A1
(en)
|
2013-03-11 |
2014-10-16 |
Zogenix Inc. |
Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
|
US10624865B2
(en)
*
|
2013-03-14 |
2020-04-21 |
Pathak Holdings Llc |
Methods, compositions, and devices for drug/live cell microarrays
|
US11744838B2
(en)
|
2013-03-15 |
2023-09-05 |
Acerus Biopharma Inc. |
Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
|
EP2981305B1
(en)
|
2013-04-04 |
2019-06-12 |
The Arizona Board of Regents on behalf of the University of Arizona |
Materials, systems, devices, and methods for endoluminal electropolymeric paving and sealing
|
EP2999747B1
(en)
*
|
2013-05-23 |
2020-08-12 |
206 ORTHO, Inc. |
Apparatus for treating bone fractures, and/or for fortifying and/or augmenting bone
|
JP2016534121A
(en)
|
2013-08-27 |
2016-11-04 |
オトノミ—,インク. |
Treatment of childhood ear disease
|
USD716450S1
(en)
|
2013-09-24 |
2014-10-28 |
C. R. Bard, Inc. |
Tissue marker for intracorporeal site identification
|
USD715942S1
(en)
|
2013-09-24 |
2014-10-21 |
C. R. Bard, Inc. |
Tissue marker for intracorporeal site identification
|
USD716451S1
(en)
|
2013-09-24 |
2014-10-28 |
C. R. Bard, Inc. |
Tissue marker for intracorporeal site identification
|
USD715442S1
(en)
|
2013-09-24 |
2014-10-14 |
C. R. Bard, Inc. |
Tissue marker for intracorporeal site identification
|
US9757330B2
(en)
|
2013-10-18 |
2017-09-12 |
Industrial Technology Research Institute |
Recipe for in-situ gel, and implant, drug delivery system formed thereby
|
US9668844B2
(en)
|
2013-11-06 |
2017-06-06 |
Colldent Y.A Ltd |
Device for fixation at a dental site
|
PT3074033T
(en)
|
2013-11-26 |
2019-02-08 |
Childrens Medical Ct Corp |
Compounds for the treatment of obesity and methods of use thereof
|
PL3089732T3
(en)
*
|
2013-12-31 |
2023-12-27 |
Pb&B Sa |
Controlled release fatty acid compositions for use in body reconstruction and body-shaping
|
GB201404139D0
(en)
|
2014-03-10 |
2014-04-23 |
Rb Pharmaceuticals Ltd |
Sustained release buprenorphine solution formulations
|
CN111620830A
(en)
|
2014-03-14 |
2020-09-04 |
北卡罗来纳大学教堂山分校 |
Small molecules for inhibiting male fertility
|
WO2015153933A1
(en)
|
2014-04-03 |
2015-10-08 |
The Children's Medical Center Corporation |
Hsp90 inhibitors for the treatment of obesity and methods of use thereof
|
US10206932B2
(en)
|
2014-05-22 |
2019-02-19 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
WO2016172712A2
(en)
|
2015-04-23 |
2016-10-27 |
Sydnexis, Inc. |
Ophthalmic composition
|
US9421199B2
(en)
|
2014-06-24 |
2016-08-23 |
Sydnexis, Inc. |
Ophthalmic composition
|
KR20170021353A
(en)
|
2014-07-03 |
2017-02-27 |
오토노미, 인코포레이티드 |
Sterilization of ciprofloxacin composition
|
US10500303B2
(en)
|
2014-08-15 |
2019-12-10 |
Tepha, Inc. |
Self-retaining sutures of poly-4-hydroxybutyrate and copolymers thereof
|
US11382909B2
(en)
|
2014-09-05 |
2022-07-12 |
Sydnexis, Inc. |
Ophthalmic composition
|
WO2016044683A1
(en)
|
2014-09-19 |
2016-03-24 |
Tensive Controls, Inc. |
Anti-microbial peptides
|
WO2016057796A1
(en)
|
2014-10-08 |
2016-04-14 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Flowable electronics
|
US20160106804A1
(en)
|
2014-10-15 |
2016-04-21 |
Yuhua Li |
Pharmaceutical composition with improved stability
|
US10550187B2
(en)
|
2014-10-24 |
2020-02-04 |
Incept, Llc |
Extra luminal scaffold
|
AU2015341490C1
(en)
|
2014-11-07 |
2021-03-11 |
Indivior Uk Limited |
Buprenorphine dosing regimens
|
AU2015360469B2
(en)
|
2014-12-10 |
2021-03-25 |
Incept, Llc |
Hydrogel drug delivery implants
|
US10626521B2
(en)
|
2014-12-11 |
2020-04-21 |
Tepha, Inc. |
Methods of manufacturing mesh sutures from poly-4-hydroxybutyrate and copolymers thereof
|
CA2969429C
(en)
|
2014-12-11 |
2020-10-27 |
Tepha, Inc. |
Methods of orienting multifilament yarn and monofilaments of poly-4-hydroxybutyrate and copolymers thereof
|
US11382731B2
(en)
|
2015-02-27 |
2022-07-12 |
Covidien Lp |
Medical devices with sealing properties
|
WO2016168388A2
(en)
|
2015-04-14 |
2016-10-20 |
Palatin Technologies, Inc. |
Therapies for obesity, diabetes and related indications
|
EP4279064A3
(en)
|
2015-05-12 |
2024-02-28 |
Incept, LLC |
Drug delivery from hydrogels
|
CN107847432A
(en)
|
2015-05-29 |
2018-03-27 |
西德奈克西斯公司 |
D2The stabilized pharmaceutical preparations of O
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
EP3328898B8
(en)
|
2015-07-28 |
2024-04-10 |
6452728 Canada Corp. |
Trkb or trkc agonist compositions and methods for the treatment of otic conditions
|
WO2017024027A1
(en)
|
2015-08-03 |
2017-02-09 |
Tolmar International Limited |
Liquid polymer delivery system for extended administration of drugs
|
US10406098B2
(en)
|
2015-11-16 |
2019-09-10 |
Evonik Roehm Gmbh |
Injection solution comprising a non-nucleoside reverse-transcriptase inhibitor and poly(lactide-co-glycolide)
|
DK3377041T3
(en)
|
2015-11-16 |
2023-12-18 |
Medincell S A |
METHOD FOR FRAGMENTATION AND/OR TARGETING OF PHARMACEUTICALLY ACTIVE INGREDIENTS TO SYNOVIAL TISSUE
|
JP2018536484A
(en)
|
2015-11-25 |
2018-12-13 |
インセプト・リミテッド・ライアビリティ・カンパニーIncept,Llc |
Shape-changing drug delivery device and method
|
WO2017100576A1
(en)
|
2015-12-11 |
2017-06-15 |
Otonomy, Inc. |
Ciprofloxacin otic composition and kits and method for using same
|
US10286077B2
(en)
|
2016-04-01 |
2019-05-14 |
Therapeuticsmd, Inc. |
Steroid hormone compositions in medium chain oils
|
AU2017239645A1
(en)
|
2016-04-01 |
2018-10-18 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
AU2017274190A1
(en)
|
2016-06-03 |
2018-12-13 |
Lifecell Corporation |
Methods for localized modification of tissue products
|
KR102552356B1
(en)
|
2016-08-26 |
2023-07-07 |
에스케이 조인트 벤처스 |
Biodegradable polymer formulations for enhancing the potency of botulinum toxin
|
WO2018053173A1
(en)
|
2016-09-16 |
2018-03-22 |
Otonomy, Inc. |
Otic gel formulations for treating otitis externa
|
WO2018055615A1
(en)
|
2016-09-22 |
2018-03-29 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Injectable implants
|
KR20230053707A
(en)
|
2016-09-23 |
2023-04-21 |
인셉트, 엘엘씨 |
Intracameral drug delivery depots
|
US11072642B2
(en)
|
2016-11-09 |
2021-07-27 |
Mayo Foundation For Medical Education And Research |
MANP analogues
|
AU2017376132A1
(en)
*
|
2016-12-12 |
2019-07-11 |
Neuronoff, Inc. |
Electrode curable and moldable to contours of a target in bodily tissue and methods of manufacturing and placement and dispensers therefor
|
JP2020501660A
(en)
|
2016-12-22 |
2020-01-23 |
ライフセル コーポレーションLifeCell Corporation |
Apparatus and method for cryocutting tissue
|
AU2018217064A1
(en)
|
2017-01-31 |
2019-08-08 |
Veru Inc. |
Compositions and methods for long term release of Gonadotropin-releasing hormone (GnRH) antagonists
|
US10646484B2
(en)
|
2017-06-16 |
2020-05-12 |
Indivior Uk Limited |
Methods to treat opioid use disorder
|
US20200276209A1
(en)
|
2017-09-11 |
2020-09-03 |
Sage Therapeutics, Inc. |
Methods of treating epilepsy or status epilepticus
|
AU2018351051A1
(en)
|
2017-10-18 |
2020-03-19 |
Lifecell Corporation |
Adipose tissue products and methods of production
|
US11123375B2
(en)
|
2017-10-18 |
2021-09-21 |
Lifecell Corporation |
Methods of treating tissue voids following removal of implantable infusion ports using adipose tissue products
|
CA3075106A1
(en)
|
2017-10-19 |
2019-04-25 |
Lifecell Corporation |
Flowable acellular tissue matrix products and methods of production
|
US11246994B2
(en)
|
2017-10-19 |
2022-02-15 |
Lifecell Corporation |
Methods for introduction of flowable acellular tissue matrix products into a hand
|
WO2019083855A1
(en)
*
|
2017-10-23 |
2019-05-02 |
Endologix, Inc. |
Endoluminal device and polymer
|
SG11202004525TA
(en)
|
2017-12-18 |
2020-06-29 |
Foresee Pharmaceuticals Co Ltd |
Pharmaceutical compositions having a selected release duration
|
WO2019154895A1
(en)
|
2018-02-08 |
2019-08-15 |
Strekin Ag |
Gel formulation for preventing or treating hearing loss
|
JP2021530480A
(en)
|
2018-07-09 |
2021-11-11 |
リジェネロン・ファーマシューティカルズ・インコーポレイテッドRegeneron Pharmaceuticals, Inc. |
Adjustment of release rate in hydrogel
|
TW202027725A
(en)
|
2018-09-25 |
2020-08-01 |
愛爾蘭商托爾瑪國際有限公司 |
Liquid polymer delivery system for extended administration of drugs
|
EP3946547A4
(en)
|
2019-03-26 |
2023-01-18 |
Pocket Naloxone Corp. |
Devices and methods for delivering pharmaceutical compositions
|
CN114144169A
(en)
|
2019-05-27 |
2022-03-04 |
托尔玛国际有限公司 |
Leuprolide acetate compositions and methods of using same for treating breast cancer
|
MX2021014654A
(en)
|
2019-05-30 |
2022-03-11 |
Lifecell Corp |
Biologic breast implant.
|
GB2601922A
(en)
|
2019-06-27 |
2022-06-15 |
Layerbio Inc |
Ocular device delivery methods and systems
|
EP4025184A1
(en)
|
2019-09-02 |
2022-07-13 |
Camurus AB |
Formulations and treatment methods
|
KR20220075338A
(en)
|
2019-09-30 |
2022-06-08 |
톨마 인터내셔날 리미티드 |
Liquid Polymer Compositions and Systems for Prolonged Delivery of Peptides as Active Pharmaceutical Ingredients
|
WO2021071974A1
(en)
|
2019-10-07 |
2021-04-15 |
Oak Crest Institute Of Science |
Orally implantable drug delivery device
|
AU2020391230A1
(en)
|
2019-11-27 |
2022-06-09 |
Oak Crest Institute Of Science |
Sustained release drug delivery device
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
US11278709B1
(en)
|
2021-03-12 |
2022-03-22 |
Pocket Naloxone Corp. |
Drug delivery device and methods for using same
|
WO2023278695A1
(en)
*
|
2021-06-30 |
2023-01-05 |
The University Of North Carolina At Chapel Hill |
Injectable, biodegradable and removable polymer based drug suspension for ultra-long-acting drug delivery
|
AU2022351480A1
(en)
|
2021-09-21 |
2024-03-28 |
Laboratorios Farmacéuticos Rovi, S.A. |
Antipsychotic injectable extended-release composition
|
CN114404659B
(en)
*
|
2021-12-06 |
2022-09-16 |
中国科学院长春应用化学研究所 |
Tubular material, preparation method and application thereof
|
WO2023133517A1
(en)
|
2022-01-06 |
2023-07-13 |
Oak Crest Institute Of Science |
Subdermal implant for sustained drug delivery
|